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ABSTRACT

Stress has been related to increased plasma epinephrine (E), norepinephrine (NE),
and glucocorticoids. These compounds produce immunomodulatory effects by interacting
with hormone receptors on or in various immune cells. This project assessed the effects o f
stress on equine influenza virus (EIV)-specific and mitogen-induced lymphoproliferation
o f peripheral blood mononuclear cells (PBMCs) in relation to stress-induced changes in E,
NE, and cortisol. In vitro effects o f amines on proliferative responses and glucocorticoid
receptor (GR) assays were done as a secondary measure o f hormone and neurotransmitter
interactions with the immune system.
Time-dependent, saturable-specific hormone binding to GRs was abolished by heat
treatment and subcellular localization o f GR fluctuated in a diurnal manner. Nuclear GR
was lowest (P<0.05) at 2AM and total binding was highest (P<0.05) at 2PM. In
experiment two, horses were subjected to five different stress tests including sham/stalled
(SS), sham/psychological (SP), minimal exercise stress (MES), slow gallop/moderate
exercise stress (SG), and fast gallop/intense exercise stress (FG). Circulating
concentrations o f E increased in SG and FG. Influenza-specific blastogenesis increased
(P<0.05) during the sham/stalled stress test. Mitogen-induced lymphoproliferative
responses were lower (P<0.05) for samples collected during MES. There was no
correlation between stress-induced hormone concentrations and lymphoproliferative
responses.

xii
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Norepinephrine stimulated (P<0.05) mitogen-induced lymphoproliferation in vitro.
ElV-specific lymphoproliferation was not affected by E or NE. Isoproterenol stimulated
mitogen-induced lymphoproliferation. Thus, P-adrenergic receptors may be related to
stimulatory effects o f NE.
Ponies were subjected to SS, MES, SG, and FG. Circulating cortisol
concentrations decreased (P<0.05) during SG and FG. Lymphoproliferation did not
change relative to stress. Prior history o f the ponies and measurable cortisol
concentrations suggested that long-term effects o f rearing processes are important to the
stress response in adult animals.
Results from this study suggest that stress-dependent changes in E, NE, and
glucocorticoid concentrations are unlikely to be primary mediators for stress-induced
changes in lymphoproliferative responses. Other putative factors or a combination of
hormones and amines may be involved in stress-induced modulation o f
lymphoproliferation.

xiii
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CHAPTER I: INTRODUCTION
The equine industry is largely dependent on pleasure, performance, and race horses
that are all subjected to varying degrees o f physical exertion. Typically, horses are
shipped to locations where they are exposed to a large and/or a new population of
animals. Horses stressed by intensive exercise regimes associated with racing and
performance activities and horses subjected to transportation stressors are susceptible to
common and serious infections including influenza (1). Outbreaks o f influenza may have a
serious impact on the equine industry since epidemics o f influenza virus infections have
caused large economic losses as well as loss o f life (1). Available vaccines do not provide
adequate protection against influenza virus infection (2). This research project was
performed to improve our understanding o f the relationship between stress and the impact
that stress may have on the incidence and severity o f disease.
Stress has been broadly defined as response o f the body to any stimulus that
disturbs its normal physiological equilibrium or homeostasis (3). The classical response to
stress involves activation o f the hypothalamic-pituitary-adrenal (HP A) axis and associated
release o f glucocorticoids and catecholamines (4). Stress-induced effects on the immune
system may be mediated by hormones o f the HPA axis, autonomic outflow, or a wide
range o f humoral compounds that may be released in response to a specific stressor. The
combination and amount o f humoral compound that may be released depends on the type,
intensity, and duration o f a stressor as well as the history o f the subject, the subjects
perception o f a stressor, and whether environmental/sociocultural factors contribute to
recovery from stress (5).

1
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I proposed that I would initially study the relationship between stress-dependent
secretion o f glucocorticoids and catecholamines and selected immunological parameters.
The rationale for this was that all stressors are associated with the release o f
glucocorticoids and catecholamines. Further, both o f these compounds could easily
contribute to changes in resistance to disease since they effect a wide variety o f
immunological functions in numerous species (6 - 9). The effects that these compounds
may have on equine immune function have not been clearly defined.
In the first set o f experiments, endpoints were established in order to demonstrate
glucocorticoid receptors (GR) in equine PBMCs and determine if there were diurnal
fluctuations in total, cytosolic, or nuclear GR. This experiment would also help to identify
time points when nuclear GR was available to produce effects on transcription or interfere
with the effectiveness o f catecholaminergic stimuli. The second set o f experiments was
done to characterize norepinephrine (NE) and epinephrine (E) in the circulation o f horses
at rest and horses subjected to different stressors in order to get a better idea o f release
that may be typical for the equine species. Effects o f these same stressors on mitogen- and
equine influenza virus (ElV)-induced lymphoproliferation were also tested. Finally, I
tested for a correlation between catecholamine concentrations and lymphoproliferation.
The third set o f experiments was designed to test in vitro catecholamine effects on
mitogen- and EIV- induced lymphoproliferation and to obtain preliminary data on the type
of receptor class that might be involved in E and/or NE effects. Finally, the fourth set of
experiments characterized cortisol concentrations in resting and stressed ponies. These
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experiments measured mitogen-induced and ElV-specific proliferation and tested for a
correlation between cortisol concentrations and lymphoproliferation.
The information gained from this work may provide data for future
pharmacological studies which evaluate whether specific neuroendocrine compounds may
be used to enhance the effectiveness o f existing influenza vaccines. This data may also
help to elucidate therapeutic measures to improve the management o f equine
immunological functions when animals are subjected to psychological, infectious, or
physical stressors.
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CHAPTER II: LITERATURE REVIEW
A. Anatomical Relays Involved in the Stress Response
Pathways important to coordinating function o f the nervous, endocrine, and
immune systems include clearly discemable anatomical connections and less clearly
defined humoral interactions which were originally attributed to hormone functions (6,
10). This research project was designed to study activity o f the hypothalamo-pituitaryadrenal (HPA) axis and autonomic nervous system (ANS) in relationship to basal and
stress-induced changes in the proliferative response o f peripheral blood mononuclear cells
(PBMCs).
I. Hypothalamo-Pituitary-Adrenal Axis
The HPA axis plays a central role in mediating the effects o f stress on immune
function (4, 10, 11). Stimuli activating the hypothalamus cause the release of
corticotropin-releasing-factors (CRFs) which stimulate pituitary corticotropes to secrete
pro-opiomelanocortin (POMC) peptides including adrenocorticotropin (ACTH).
Secretion o f ACTH stimulates cortisol release from the adrenal cortex (12, 13).
Adrenocorticotropin is the primary regulator o f cortisol synthesis and release.
However, elevated plasma corticosteroid concentrations have been measured when there
is not a coincident increase in plasma ACTH concentrations (14, 15). Three possible
mechanisms for ACTH-independent corticosteroid release have been described including
direct autonomic innervation o f the adrenal cortex by cholinergic nerves, indirect
activation o f the adrenal cortex by paracrine secretions such as epinephrine or co-localized
interleukin (IL)-l, and the release o f other hormones that regulate sensitivity o f the

4
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adrenal cortex to ACTH (16). Putative factors that may be involved in the latter activity
include y -3-melanocyte stimulating hormone (y-3-MSH), growth hormone,
prostaglandins, interferons, and other peptides (16).
Gamma-3-melanocyte stimulating hormone is a cleavage product o f POMC (16).
Gamma-3-melanocyte stimulating hormone enhances ACTH-dependent release o f
corticosterone in vitro and in vivo (16). In general, y-3-MSH is secreted with ACTH but
it probably does not play a role in the absence o f ACTH (16).
Growth hormone potentiates the effects o f ACTH in hypophysectomized rats but it
has no independent effect on cortisol secretion (17). Prostaglandins can also increase
steroidogenesis in the adrenal gland (15) but the physiological significance o f
prostaglandin effects on glucocorticoid synthesis has not been elucidated.

In addition to

the aforementioned substances, factors derived from the thyroid gland, the liver, and the
thymus may potentiate ACTH effects on steroidogenesis in isolated or in in vitro
preparations o f the adrenal cortex (15). Other humoral factors that may effect sensitivity
o f the adrenal gland to ACTH include lymphokines derived from lymphocytes or from
chromaffin cells o f the adrenal medulla (14, 15).
A number o f factors regulate hormone release from pituitary corticotropes.
Corticotropin-releasing factors bind to pituitary corticotropes to stimulate synthesis o f
POMC and release o f ACTH and other adenohypophyseal products o f POMC (11).
Vasopressin acts through V, receptors to amplify corticotropin releasing hormone (CRH)
effects on ACTH secretion (11). Oxytocin has also been shown to enhance the effect o f
CRH on ACTH secretion (11).
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Catecholamines stimulated murine pituitaries to secrete ACTH by acting on alpha1- and beta-adrcncrgic receptors (4). Angiotensin-II has also been shown to increase
secretion o f ACTH in various animal models (11). Other factors including vasoactive
intestinal polypeptide, serotonin, and atrial natriuretic factor control POMC synthesis,
processing, and/or release o f its hormone products in horses (18, 19).
Central regulation o f the HPA axis has been related to brain structures which
include the amygdala, hippocampus, septal area, cingulum, orbital cortex, and brainstem
regions (20, 13). The HPA axis is also influenced by changes in blood volume, body
temperature, and pain (20). These stimuli act through neural pathways typically involving
adrenergic innervation o f the hypothalamus by cell groups with perikarya localized in the
brainstem (21). Catecholamines have divergent effects on central control o f the HPA axis.
In rats, catecholamines have a stimulatory effect on the HPA axis by acting on alphaadrenergic receptors and an inhibitory effect mediated by beta-adrenergic receptor
activation (20). Neurotransmitters like gama-aminobutyric acid (GABA), morphine, and
opiates also have an inhibitory effect on activity o f the HPA axis (20).
Glucocorticoids play an important role in controlling the secretion o f hormones
from the hypothalamus, pituitary, and the adrenal medulla (Figure 1). They have a
negative feedback effect on the pituitary, hypothalamus, and extra-hypothalamic areas
(22). Chronic stress and glucocorticoids down-regulate glucocorticoid receptors (GR) in
extra hypothalamic areas o f rats, reduce responsiveness o f the hippocampus to negative
feedback, and gradually destroy neurons in the hippocampus (Figure I).
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S t a g e s of glucocor ticoid a c t i o n
Pi t ui t a r y

on h i p p o c a m p u s
1. N e g a t i v e f e e d b a c k
2 Receptor down-regulation
3 . N e u r o n a l loss

Adrenal
Co r te x

O t h e r h o r m o n e s i n f l u e n c ed
by g lu c o c o r t i c o i d s
A CT H , , 8 - e n d o r p h i n
V a s o p r e s s i n , oxytocin, CR F

G l u c o c o r t i c oi d E f f e c t s on

Eoinephrine

Pathophysiology

Enkephalin

Immunosuppression

Thymosin

Muscle a t r o p h y
Osteoporosis/hypercalcem ia
Hyperglycemia/hyperlipidemia
Arteriosclerosis

Interleukins
G r o w t h h o r m o n e , thyroid
s t i m u l a t i n g h or m o ne ,
prolactin

Steroid d iab ete s

Figure 1: Hypothalamo-pituitary-adrenal axis and feedback control. This figure
summarizes relationships important to glucocorticoid feedback on the hypothalamopituitary-adrenal axis. The figure also summarizes glucocorticoid effects on other body
systems and the hippocampus as well as glucocorticoid effects on the secretion o f the
other hormones (adapted from McEwen (23) with permission).
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2. Autonomic Nervous System Innervation o f Lymphoid Tissue
Innervation o f lymphoid tissues by the ANS has been well characterized in
vertebrates (Figure 2). Lymphoid organs and tissues including the tonsils, jugular body,
thymus, thoracic duct, lymph nodes, spleen, Peyers patches, cistema chyli, appendix, bone
marrow, and bursa fabricius are innervated (24). Recent research has demonstrated that
this innervation can effect immune responses when neurotransmitters bind to specific
receptors on lymphocytes and other immune tissues or neurotransmitters may regulate the
immune cell environment (25, 26).
Bone marrow is innervated by nerves that enter through the nutrient foramen of
the bone (27). Myelinated and unmyelinated nerves divide repeatedly into several nerve
bundles that run along the course o f the nutrient artery. There is substantial innervation o f
hematopoietic sites such as the sinusoidal parts and parenchymal elements (27).
Myelinated nerves are found alone or within bundles o f unmyelinated nerves and they are
less numerous then unmyelinated fibers in newborn rats.
The thymus is a primary organ o f the immune system. It is a specialized gland
capable of supporting maturation o f T lymphocytes (28) and in mice it regulates
development and integrity o f the HPA axis (6, 29). Vagal nerve fibers o f the ANS
innervate the thymus early in development (30). The vagus nerve develops complex
corticomedullary boundary nerve nets as the thymus completes development. Vagal fibers
aid in structural maturation o f the thymus and innervation is followed by migration o f T
lymphocyte precursor populations into the gland (30) During the perinatal and
prepubescent periods other ANS nerves penetrate parenchyma o f the thymus (29). The
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Figure 2: ANS innervation of lymphoid tissue. This figure illustrates autonomic
nervous system innervation of different lymphoid organs and tissues based on research
results from mice and chickens. Lymphoid organs and tissues include tonsils, the jugular
body, thymus, thoracic duct, lymph nodes, spleen, Peyer*s patches, cisterna chyli,
appendix, bone marrow, and bursa fabricius. (adapted from Bulloch (24) with permission).
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thymus in adult mice is supplied by the vagus, phrenic, and the recurrent laryngeal nerves
as well as the superior cervical and stellate ganglia o f the cervical and thoracic sympathetic
chain (3 1). Innervation o f the thymus gland is similar in various species (32). Nerves
innervating the thymus o f rats and mice have their cell bodies in the nucleus ambiguous
and the nucleus reteofaciola (30, 32). Cell bodies are also localized in three distinct
columns in the cervical spinal cord (C1-C4) and in the nodose and superior cervical
ganglia (32, 33). Studies on innervation o f the thymus in chicks have reported similar
localization o f cells which project to the thymus (33).
The thymus contains the primary parasympathetic neurotransmitter acetylcholine
and the sympathetic neurotransmitter norepinephrine. It also contains other ANS-related
neurosubstances and hormones such as Substance P, vasoactive intestinal peptide,
somatostatin, neurotensin, GABA, and calcitonin (24).
The bursa o f Fabricius, a small, oval, hollow organ which lies at the end o f the
cloaca in birds, is the site o f B cell genesis (34). A layer o f tissue lining the lumen o f the
bursa contains lymphoid tissue. The bursa is supplied by nerves derived from the pelvic
plexus which include both sympathetic and parasympathetic fibers (35). Although some o f
the nerve fibers enter the nodules, most o f the lymphoid tissue is superficially innervated
(35). The adult bursa also contains micro-ganglia which are derived from a single
ganglion during embryogenesis (36).
The spleen is a secondary lymphoid organ capable o f protecting the body against
blood-borne pathogens (37). Normally T and B lymphocytes are transported via the
splenic artery as they enter the spleen and they are spread within specific zones o f the
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white pulp (37). The spleen is primarily innervated by the celiac ganglion (24). The celiac
ganglion receives input from CNS nerves that originate in the medial column o f the
thoracic spinal cord (T5-T9) and traverse the upper and lower splanchnic nerves (24).
The majority o f splenic nerves project directly to the parenchyma along the trabecular
arteries to enter the arteriole trees o f the white pulp (38). Occasionally, nonvascularassociated fibers stretch into the white pulp and are located in close proximity with
lymphocytes (38). In mice and in cats, catecholaminergic innervation terminates at the
junction between the splenic white and red pulp (39). In other strains o f mice,
catecholaminergic innervation to the red pulp is limited (38). In addition, the vagus nerve
effects the spleen indirectly by innervating the splenic artery (37). The spleen also
contains catecholamines derived from the circulation (39).
The lymphatic system transports lymph and lymphatic cells in the body through a
number o f interconnecting vessels. Sympathetic and parasympathetic fibers innervate fully
developed lymphatic tissues (40). The thoracic duct, which is a major lymphatic duct, is
innervated by the vagus and the intercostal nerves (41). The cistema chyli is supplied by
the Xlth thoracic ganglion and the left splanchnic nerve (40). Lymphatic ducts in the
lower body are innervated by the femoral nerve and by lymphomotor nerve fibers that
parallel the femoral artery in canine (42). In addition, small ganglia and periadventitial
nerve plexuses surround the thoracic duct and other lymphatic channels (41).
Lymph nodes are highly organized structures o f the immune system which are
distributed throughout the body (24). Lymph nodes contain both T and B lymphocytes
(24). Each region o f the body contains defined afferent lymphatics which are drained by a
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node or set o f nodes (40). Innervation of lymph nodes by ANS fibers is different from that
found in thymus and spleen as it is not as dense or as regionally organized (30).
However, acetylcholinesterase-positive fibers are confined to the capsule and
subcapsullary zones whereas catecholaminergic fibers form perivascular plexuses inside
lymph nodes (30, 43). It is rare to find fibers in the deeper layers o f the germinal center in
lymph nodes o f mice and only a few nerve fibers are typically visible in the parenchyma
(30, 43). Strain differences have not been detected in innervation o f lymph nodes (30).
Peyer’s patches are assemblies of lymphoid nodules located in the intestinal
mucosa (40). They consist o f compact lymphatic tissue and have a large lymphopoietic
reaction center surrounded by a layer o f dense reticular fibers (40). Peyer’s patches
predominantly have specialized functions related to the mucosal immune response (44).
The origin o f nerves that innervate Payer's patches has not been characterized. However,
reticular cells in mice have been associated with axons and synaptic-like contacts while
lymphocytes have been found to be related to axon terminals containing synaptic vesicles
(40).
The appendix or vermiform process is the lymphoid tissue associated with the
gastrointestinal system (40). Submucosa o f the appendix contains a large amount o f
lymphoid tissue which is segregated into different regions (45). Lymph nodules and T
cell-dependent lymphoid areas are traversed by large linear branches o f varicose nerve
fibers that facilitate interactions between neurotrophic factors and local immune responses
in rabbits (45).
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B. Biological Significance o f Stress
Recent progress has been made in elucidating neurobiological processes involved
in the stress response. Biological changes that occur during stress include an array of
responses that have been described as the "flight or fight" defense response (9). Normally
these biological responses prepare the organism to cope with stress by increasing the
readiness and reactive behaviors and biological functions that will increase the probability
o f survival.
Figure 3 shows some o f the social, psychological, and personal characteristics
which may result in individual differences in activation o f the HPA axis and the ANS as
well as changes in immune functions and health that may be related to a particular stressor
(9). Exposure to stress that is perceived as uncontrollable characteristically results in
impaired immunological functions (46), increased catecholamine release (47), increased
activity o f the o f HPA axis (48), and a greater incidence o f neurodegenerative disorders
(49). Clinical studies in humans have revealed that stress is associated with the onset of
depressive and physical illnesses (49, 50). Stressful events that are associated with the
onset o f depression are usually perceived as uncontrollable and therefore present a feeling
o f powerlessness. A few examples of such events are death o f a close relative and serious
illness (51). Prevention and treatment o f stress-related disorders can be improved by
elucidating biological factors that mediate these changes and by identifying immune cell
types and immunological functions that are adversely effected by specific compounds.
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C. Neuroendocrine-immune interactions
Research has demonstrated significant bi-directional communication between the
nervous, neuroendocrine, and immune systems (6). The interrelationship between immune
and neuroendocrine circuits is illustrated in Figure 4. The central nervous system (CNS),
pituitary gland, and the immune system communicate directly and indirectly (10, 52).
Immune functions altered by nervous and neuroendocrine systems include
ontogeny o f T and B cells, accessory cells, and the development and function o f bone
marrow, thymus, lymphocytes, and spleen o f humans (9). The nervous and
neuroendocrine systems also regulate migratory patterns o f cells from bone marrow to
thymus and homing o f immune cells (30).
Nervous system and neuroendocrine effects on the immune system are mediated by
neuroactive substances that act as paracrine, neurocrine, or hormonal effectors (10).
Catecholamines and glucocorticoids are believed to be the primary effectors involved in
neural and neuroendocrine regulation o f immune function (8). The immune system
secretes a number o f compounds that may feed back on neural and neuroendocrine cells to
modify immune function (53). In addition, infection and/or various diseases cause the
release of compounds from the immune system that act to elicit changes in function o f
neural and endocrine systems (9, 54). Cytokines are believed to be the most important
effectors involved in immunological effects on neural and neuroendocrine systems (53). It
has also been shown that activated lymphocytes produce ACTH-, y-endorphin-, thyroidstimulating hormone, and human chorionic gonadotropin-like peptides (8, 55). These
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lymphocyte secretions may act to directly control endocrine function by conventional
mechanisms or these secretions may act on other cells in the immune system (54, 57).
1. Glucocorticoids and the Immune System
Glucocorticoids are released following activation o f the HPA axis (12).
Glucocorticoid effects on the immune system were recorded in the mid-nineteenth century
when it was noted that there were more white blood cells in an Addison’s disease patient
(58). The importance o f glucocorticoids to immune function was verified in the mid
forties when it was reported that injection o f ACTH increased antibody titers in humans
(59). It was also demonstrated that stress-induced secretion o f glucocorticoids stimulated
defense mechanisms and increased resistance to stressful conditions (59). These results
were not reproducible when improved immunological assays were used (60).
It was in the 1950's that physicians referred to glucocorticoids as the miracle drug
for allergic syndromes (12). This development followed pre-clinical research that
demonstrated immunosuppressive and anti-inflammatory actions o f glucocorticoids (61).
The physiological role o f normal glucocorticoid concentrations was not fully appreciated
at that time (12, 60).
By the time that the role o f the HPA axis in regulating the immune system started
to be established mechanisms involved in regulating lymphoid tissue were fairly well
characterized. Evidence demonstrating a physiological role for the HPA axis in regulating
the immune system included observations on hypertrophy o f the thymus in
adrenalectomized rats (62) and thymus atrophy associated with stress-induced adrenal
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enlargement in rats (63). It had also been shown that purified steroid extract from the
adrenal cortex could reverse thymic atrophy (63). Furthermore, research in rats and mice
has shown that increased blood corticosterone levels parallel increases in immune response
to experimentally injected antigen (6). Subsequent studies demonstrated that
adrenalectomy abrogated the aforementioned effects (64).
Many o f the immunosuppressive actions o f glucocorticoids are observed at steroid
concentrations that are equivalent to therapeutic and/or stress-induced levels (65).
Glucocorticoid therapy that is commonly utilized in clinical situations has a wide variety of
effects on the immune system. The suppressive effects seen following acute treatment
with glucocortiocids continue as long term effects in humans (10). Acute effects o f
glucocorticoids have been related to leukocytosis, neutrophilia, decreased pan T cells, and
monocytosis (10). Glucocorticoids inhibit almost all functions o f monocytes and
macrophages including chemotaxis, antigen presentation, and cytokine release in humans
(66). Glucocorticoid effects on mononuclear phagocytes are indirectly mediated due to
the inhibition o f cytokines required to activate phagocytic function (67). Glucocorticoids
may also stimulate immunoglobulin production in humans (68). Decreased production o f
interleukin (IL) -1 and increased production o f IL-6 have also been related to
glucocorticoid release (10). Further, intravenous glucocorticoid treatment has been
reported to enhance NK cytotoxicity after 4 hours (69). Glucocorticoids and ACTH
decrease allergic, rheumatic, and collagen diseases (61).
Anti-inflammatory and immunosuppressive effects o f glucocorticoids play a role in
physiological mechanisms important to coping with various stressors (70, 65). These
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actions are induced through glucocorticoid receptor-mediated processes (71).
Glucocorticoids act on cells by binding to specific intracellular receptors and many types
o f immune cells, in various species, have glucocorticoid receptors including murine
lymphoma hybrids (72) and PBMCs (73).
There are two types o f glucocorticoid receptors in mammalian species (74). The
type I receptor has a high affinity (KD= 0.5 nM) and low capacity for glucocorticoids and
it is analogous to the classical mineralocorticoid receptor localized in the kidney, salivary
glands, and colon (74). The type II receptor, is similar to the classical glucocorticoid
receptor (GR) localized in the liver (74). This receptor has an lower affinity and higher
capacity for glucocorticoids.
Hormone binding to the GR activates the receptor and increases its affinity for
chromatin (Figure 5). Hormone-bound GR binds to glucocorticoid response elements
(GREs) which regulate transcription of various genes (75). Glucocorticoid effects may
also involve binding to GREs that overlap binding sites for the cAMP response element
binding protein (CREB) (6). This interaction may block or reduce the effectiveness o f
stimuli acting through cAMP cascades. Further, hormone occupied GR may bind to sub
units o f AP-I protein and prevent the action o f AP-1 nuclear protein dimers on
transcription (76, 77). This then modifies early activation o f cells effected by protein
kinase C-dependent stimuli. Thus, glucocorticoid effects on cells may involve direct
genomic effects on transcription, genomic effects that alter cAMP-dependent
transcription, or genome-independent protein interactions that alter effectiveness o f A P-1
dependent stimuli.
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2. Catecholamines and the Immune System
Catecholamine release caused by physical or psychological stress depends on
activation o f the CNS and the related response o f the ANS (78). Acute systemic release
o f catecholamines during exercise stress has been related to reduced lymphoproliferation
in murine species (79). Further, denervation and/or pharmacological treatments that
prevent neurotransmitter release in or from the adrenal medulla, thymus, or lymph nodes
may alter specific immunological functions such as in vivo proliferation o f immune cells in
lymph nodes, spleen, and bone marrow (21, 80). For example, in mice, chemical
sympathectomy diminished the primary antibody response by as much as 80% and 97% in
spleen and lymph nodes, respectively. Denervation and/or pharmacological blocks of
sympathetic transmitter release also reportedly reduced the secondary antibody response
and resulted in a 50% reduction in T cell-mediated responses including delayed
hypersensitivity to epicutaneous immunization and cytotoxic T-lymphocyte response to
alloantigens (21, 37, 80). The same experimental reports described enhanced
Iipopolysaccharide-stimulated proliferation and enhanced immunoglobulin production by
lymph node cells following denervation or pharmacological block o f sympathetic activity.
These findings may be o f considerable importance to veterinary medicine since production
o f neutralizing antibodies is dependent on T cell help and such antibodies are necessary for
protection against equine influenza infection (81).
Catecholamines regulate lymphocyte trafficking, vascular permeability, and blood
flow in lymphoid organs (21). Chemical sympathectomy increased the prevalence of 0adrenergic receptors on murine lymphocytes and caused complete loss o f NE in rat spleen
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and other innervated organs (37). Sympathectomy altered the distribution o f murine
lymphocytes in the spleen and abolished efflux o f leukocytes from spleen (21).
Sympathectomy in 8-week-old mice caused a reduction in the percentage o f T and B cells
in the spleen (21). Neonatal sympathectomy also caused an alteration in the relative
percentage o f T-cell subsets within the spleen due to decreased numbers o f CD8* cells in
sympathectomized mice (37). Although the percentage o f T cells was not changed
following sympathectomy, the proportion o f CD8+ cells was 50% o f that counted in
control mice.
The severity and incidence o f autoimmune diseases may be increased by
sympathectomy (82). Antibody-mediated, but not T-cell-dependent and T-cell-mediated,
autoimmune diseases were significantly augmented after sympathectomy (82).
Sympathectomy also affects NK cells. Sympathectomized 2-week-old CBA mice initially
had relatively low levels o f NK activity, which increased at 4 weeks, and subsequently
declined to low-Ievels by 6 weeks (82). The transient increase in NK function after
sympathectomy was attributed to loss o f the restraining influence o f catecholamines on
NK activity or to effects o f the sympathetic nervous system on migration patterns or
maturation o f splenic NK cells (82).

In vivo experiments have demonstrated that blood mononuclear cell subsets as well
as NK cell and lymphocyte functions were altered during stress and 2 hours after exercise
stress (83). These effects were mimicked by exogenous administration o f epinephrine
(83). Epinephrine induced smaller increases in leukocyte concentrations compared to the
cell concentrations measured in stressed humans (83).
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Catecholamines alter immunological functions by binding to multiple classes o f P
and cc-adrenergic receptors. Studies performed in a number o f species (human, rat,
mouse, guinea pigs, rabbit) suggest that the most dramatic and wide-spread effects o f
catecholamines are dependent on P-adrenergic receptors (reviewed in 84). Betaadrenergic agonists inhibited T cell proliferation in response to lectins or IL-2, reduced
lectin-stimulated proliferation o f B cells, and inhibited the generation o f lymphokine
activated killer (LAK) cells in humans (85). The non-specific P-agonist isoproterenol also
reduced IL-2 production by human lymphocytes and down regulated EL-2 receptors on
lymphocytes and T-cell lines (86). Mice treated with cAMP analogues, or P-adrenergic
agonists which act through cAMP cascades, had reduced cytotoxicity mediated by
antigen-specific cytolytic T lymphocytes, NK cells, and other non-specific killer cells
including macrophages and monocytes (87, 88). In addition, antibody secretion in mice
was inhibited by p-adrenergic agonists (89). Results from experiments using specific
and/or non-specific P-adrenergic antagonists have generally supported the conclusion that
catecholamine binding to P-adrenergic receptors inhibits murine immune functions (90).
Cyclic AMP, which acts as a second messenger mediating adrenergic effects, has a
role in promoting differentiation o f immature lymphocytes probably by initiating the S
phase o f mitotic division and DNA synthesis following mitogen stimulation (91). Elevated
cAMP levels in humans have been associated with the inhibition o f mature differentiated
lymphocyte functions (91). Cyclic AMP inhibited lymphoproliferation in murine species
and this effect was dependent upon inhibition o f C a " influx (92).
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Possible mechanisms for cross-talk between the trans-membrane signaling events
elicited by stimulation o f (3-adrcncrgic receptors and T-cell receptors are summarized in
Figure 6 (92). Stimulation o f T-cell receptors caused hydrolysis o f phosphatidylinositol
4,5-biphosphate (PEPz) due to activation o f phospholipase C and this yields inositol
triphosphate (IP3) and diacylglycerol (DAG). Further, EP3 can be converted into inositol
tetra phosphate (EP4) and water soluble EP3 can release intracellular sources o f C a " ions
whereas IP4 may regulate plasma membrane Ca*" ion channels in mice (92). Protein
kinase C and increased Ca"* may inhibit increases in cAMP that are induced by betaadrenergic stimulation (84).
Alpha-adrenergic receptor stimulation by catecholamines enhanced proliferation
o f CD3*, CD4*, and CD8* lymphocytes in humans (84, 93). These catecholaminergic
effects were more pronounced for CD8* than for CD4* cells (84, 93).
The existence o f adrenergic receptors on lymphocytes, monocytes, and neutrophils
was demonstrated in the early 1980s (94 - 96). Typically P- adrenergic receptors are
found on murine and human B and T lymphocytes (84, 93). Receptor density varies
among subsets o f T cells, with the number o f receptors on human T suppressor/cytotoxic
cells being greater than that on T helper cells (93). Further, CD8" cells have many more
P-adrenergic receptors than CD4+ cells and the number o f P-adrenergic receptors per cell
has been correlated with prolife .tive response o f these cells (93). There is limited
information on immune cells with cc-adrenergic receptors and whether immune cells and
tissues in the equine species have adrenergic receptors has not been investigated.
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Figure 6: Proposed mechanisms for P-adrenergic effects on T cell activation. The
possible mechanisms for cross-talk between transmembrane signaling events elicited by
stimulation o f P-adrenergic and T-cell receptors are summarized in this schematic. AC =
adenylate cyclase; BAR = beta adrenergic receptor; Ca = calcium ions; cAMP = cyclic
AMP; DAG = diacyl glycerol; ER = endoplasmic reticulum; G = G protein; Gs =
stimulatory G protein; IP = phosphoinositol; PEP2= phosphatidylinositol 4,5-biphosphate;
PKA = protein kinase A; PKC = protein kinase C; PLC = phospholipase C; TCR = T-cell
receptor; (Adapted from Roszman and Carlson (92) with permission).
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D. Infection and Disease Potential o f Stress
The pioneering work o f Dr. Seiye demonstrated that restraint and injury frequently
result in disease (97). Subsequent studies have demonstrated that various stressors
including, physical, chemical, and psychosocial stress may have drastic effects on immune
function and the related susceptibility to disease. Prolonged aggravated stress, psychotic
states, and disorders o f the ANS or the endocrine systems disrupt cortical control o f
neuroendocrine regulation and have detrimental effects on immune function (98, 99).
Stress associated with unpleasant and grieving personal experiences has been
correlated with the sudden onset o f disease (100). Humans that suffer from chronic
distress, irritation, and frustration ultimately became discouraged, chronically depressed,
and they contract a variety o f diseases (5, 101). Obese humans on high fat diets but with a
lifestyle including social cohesion, close personal relationships, and little sociocultural
change, had a lower incidence o f coronary atherosclerosis, sudden death, and/or
myocardial infarction as compared to matched subjects that suffered from chronic stress
(102, 103). Bereaved persons not only change their lifestyle but also are at risk for a wide
variety o f diseases or the exacerbation o f existing diseases (100). Plasma corticosteroid
levels were elevated in some bereaved persons (100). Older subjects o f both sexes who
were facing bereavement, or who had been widowed, had higher urinary levels of
norepinephrine or epinephrine when they were anxious or depressed as compared to
matched subjects who were not coping with death o f a closely associated individual (104).
In high risk populations, the probability that stress will induce disease is 0.14 (105).
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The incidence o f coronary artery disease (CAD) is normally very low in stable
communities and societies (106). However, coronary atherosclerosis develops early in the
life o f young men and evolves over many years and stressors during this period may
interact to increase the development or severity o f CAD (107). Blue collar workers who
do heavy manual labor or shift work and/or chronic work overload are generally exposed
to excessive noise and these conditions have been related to a higher incidence o f
myocardial ischemia (108). Brief separation o f young animals from their mother
reportedly results in high blood pressure, persistent elevations o f basal heart rates,
disturbances in growth, sleep, and body temperature regulation, persistent
immunosuppression, and a predisposition to opportunistic infection (109).
Mental depression has been associated with a greater number o f eruptions in
individuals with chronic recurrent herpes simplex infections (110). In addition, depression
was associated with decreased CD8+ cells and this reduction preceded herpes activation
(111). It was also demonstrated that anxiety and fear preceded the recurrence o f herpes
simplex infections (111).
Physically and psychologically stressed subjects have an increased incidence o f
human immunodeficiency virus (HTV) seropositivity (112). Human immunodeficiency
virus-seropositive individuals living alone had a greater reduction in immune functions as
compared to immunological endpoints measured in matched HIV-positive controls living
with a close partner (113). Solitary HIV-seropositive humans experienced a more rapid
rate o f HIV progression based on lower levels o f CD4* T cells and a lower proliferative
response to phytohaemagglutinin (113). The same laboratory reported that prolonged
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periods o f depression in HIV-seropositive men resulted in a more rapid decline in CD4* T
cells when compared HIV-positive matched controls that were not depressed (i i4). In
HIV-positive subjects studied for an 8-week period, there was no effect o f stress on NK
cell activity or the Iymphoproliferative response to ConA, Candida albucans, or
Cytomegalo virus antigens. Immunoglobulin A and lymphocyte subsets did not change
during this study (115).
Immune functions in cancer patients have been studied in relation to psychological
stress factors. Psychosocial group interactions over a 6-week period enhanced survival o f
malignant melanoma patients and was also associated with an increase in interferonaugmented NK activity and the number o f NK cells over a 6-month time period (116).
Behavioral characteristics o f patients participating in group therapy included lower levels
o f anxiety and depression and increased levels o f anger at a 6-month follow-up point
( 1 16). Further, breast cancer patients with better coping skills had higher levels o f NK cell
activity than patients who were not as well adjusted (117). Social support and fatigue of
cancer patients also seems to play an important role in lowering NK cell activity when
measured over a 3-month period (117, 118). Animal models exposed to stress have an
increase in the morbidity and mortality o f immune-related disorders and cancer (119).
Although the preceding literature relates primarily to human subjects, studies with
animal models suggest that similar factors may affect the stress response. Based on
existing literature (2, 13, 18, 120 - 135) and results from experiments summarized in this

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

29

dissertation this also applies to the equine species. The importance o f these observations
will be discussed in more detail following presentation o f the experimental data.
E. Influenza Infection
Influenza is a pandemic viral respiratory disease which results in high morbidity
and significant mortality in humans and domestic animals (136, 137). The costs o f
influenza in terms o f economic losses can be high; costs per horse during an influenza
outbreak in a thoroughbred stable in 1975 were estimated to be $700 (136).
Influenza viruses have been divided into 3 types (A, B, C) based on antigenic
character o f their nucleoprotein and the chronological order o f isolation (138). For each
type, sub-type and strain taxonomy has been based on the antigenicity o f viral
hemagglutinin (HA) and neuraminidase (NA) antigens (138). In 1980, the World Health
Organization (WHO) recognized the classification o f fourteen antigenically distinct HA
groups and nine antigenically distinct NA groups in human, swine, equine, and avian
influenza A viruses (81). Influenza B and C viruses have no subtypes (138).
I. Biology o f Influenza Virus
Influenza is an orthomyxovirus consisting o f an outer lipoprotein envelope and an
internal helical ribonucleoprotein core termed the nucleocapsid which contains the
negative stranded viral RNA genome (55). The influenza A virus was the first
characterized virus o f the orthomyxovirus family (55). It contains ten genes divided
among eight RNA segments (55). The viral envelope is studded with two types o f surface
glycoproteins which include HA and NA (137). There are approximately 500 HA
molecules and 100 NA molecules per virus particle (137). Within the viral envelope is a
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shell comprised o f a matrix protein (MP) which encloses the RNA and associated
nucleocapsid protein (NP) as well as the proteins which are responsible for RNA
replication and transcription (137). Hybridization studies suggest that the NP can be
divided into five groups. This grouping is related to different host origins, which suggests
that NP may be involved in determining host specificity (137).
Hemagglutinin is responsible for the attachment o f virus to cells and for cell
penetration and it may also mediate cell fusion (137). Hemagglutinin and NA proteins are
expressed on the surfaces o f influenza-infected cells (55). The FLA protein undergoes
periodic antigenic changes which are most commonly due to antigenic drift that results
from the accumulation o f a series o f point mutations or less often to antigenic shift which
results from genetic reassortment between influenza A viruses from humans and animals
(137).
2. Immune Response to Influenza Virus Infection
a.

Humoral immunity. Antibodies to HA neutralize viral infectivity and

resistance to influenza infection correlates with anti-HA antibody levels in humans (139).
Antibodies to NA are less effective than anti-HA antibodies in mediating protection
against influenza infections (81). Antibody specific for viral NA reduced the severity o f
lung lesions and lowered viral titers in mice (140) and prevented systemic spread o f virus
and death in chickens (140) but NA-specific antibodies did not prevent infection in either
o f these species. Antibodies against NA may exert their effect by reducing virus yield and
cell-to-cell spread o f virus (141). It has been suggested that anti-MP antibodies may also
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contribute to anti-influenza protection, possibly by mediating antibody-dependent cellular
cytotoxicity o f infected cells (142).
Studies have demonstrated that serum antibody is sufficient to prevent infection o f
the lung (143). For example, experiments with ferrets indicated that immunization o f an
isolated tracheal pouch with influenza virus led to serum antibody and protection o f the
lung but not the nasal passages (144). The passive transfer o f serum anti-influenza
antibody to mice (145, 146) and ferrets (144) demonstrated that high titers o f serum
antibody fail to protect the upper respiratory tract against viral challenge while it protected
the lungs and prevented development o f pneumonia. In mice and adult ferrets, protection
o f the upper respiratory tract from intranasal viral challenges was not provided by serum
antibody (81). Immunoglobulin A-producing plasma cells produced antibodies specific for
orally administered antigens in rats (147). Specific antibodies were detected in the gut and
also in extra-intestinal lymphoid organs such as mesenteric lymph nodes and spleen of
immunized animals (147).
Intranasal administration o f a recombinant vaccinia virus, containing the HA gene
o f H1N1 influenza induced local protection against H1N1 influenza virus in mice (148).
Protection was correlated with an increased IgA titer in nasal washes (148). Virusspecific IgA was detected in nasal washes o f influenza-infected convalescent humans
(149). Further, it was reported that the predominant immunoglobulin in nasal washes o f
patients subjected to a secondary intranasal challenge with a H3N2 influenza virus was a
dimeric IgA which was associated with secretory component (149).
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b. Cellular immunity. Cellular immunity is necessary for recovery from
influenza infection although cell-mediated immunity probably does not contribute to
preventing influenza infection (81). Cytotoxic T lymphocytes (CTL) capable o f
recognizing eight o f the ten influenza virus encoded proteins including HA, N A MP, and
NP were generated following influenza infection o f mice (55). Cytotoxic lymphocyte
function plays a major role in the host cellular response to influenza infections (150). A
minor population o f CTLs from influenza-infected mice was capable o f recognizing HA
(55) and this cell population may play a role in recovery o f mice from challenge with an
influenza virus bearing homologous HA (151). Heterotypic immunity in mice is
presumably mediated by cross-reactive class I major histocompatibility complex (MHC)restricted CD4', C D 8 \ a/p CTLs that recognize influenza virus NP (152). However,
there was clearance o f influenza virus from respiratory tracts o f mice which lack class I
MHC-restricted CTLs (153). Bradley and coworkers (154) hypothesized that this
clearance may be due to class II MHC-restricted CTLs or secretory IgA. Although CTL
can not per se prevent infection, infection in primed persons may be modified early in its
course. As CTL recognize the common internal viral proteins also besides glycoproteins
o f outer membranes o f influenza virions, this protective effect can be broader than that of
antibody response (150).
3. Equine Influenza
Equine influenza viruses (EIVs) are categorized as type A based on antigenicity of
their internal proteins (155). Type A EIVs are divided into two sub-types based on
antigenicity related to the surface proteins HA and NA (155). Influenza viruses are
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codified according to their type, host species, subtype, and place and year o f isolation,
followed in parentheses by the HA and N A subtypes (156). Equine I influenza is
designated A/equine 1/Prague 56 (H7N7) and equine 2 influenza virus is referred to as
A/equine 2/Miami 63 (H3N8) (1). Equine influenza viruses are effected by antigenic drift
(156). An antigenic variant which gave rise to large seal disease epidemics in the late
seventies and early eighties involved A/equine 2/Fontainbleau 79 and A/equine 2/Kentucky
81 (1). More recent virus isolates include A/equine 2/Johannesburg 86, A/equine 2/
Ludhiani 87, A/equine 2/Bhiwani 87, A/equine 2/Suffolk 89, A/equine 2/Alaska 91, and
A/equine 2/Kildare 92 (157).
Equine influenza viruses are very labile and sensitive to disinfectants (1). Equine
influenza is contracted by inhalation and it is extremely contagious (158). The incubation
period varies from 1 to 5 days and depends primarily on the dose o f virus challenge (1).
The short incubation period and persistent coughing which releases large amounts o f virus
into the atmosphere contribute to rapid spread o f the disease (159).
In a susceptible group o f horses, morbidity can be as high as 100% (1). Mortality
is usually low but can be as high as 10% in foals, donkeys, and in affected horses that are
not adequately rested (1). The severity o f the disease depends primarily on the general
immune status o f horses at the time o f exposure, the environment, and the amount o f
stress that the animals are subjected to (129). Equine influenza generally has adverse
affects on breeding stock and the performance o f competition horses without causing
mortality (129). Show and race horses appear to be particularly susceptible to infection,
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probably due to frequent transport that may cause stress and exposure o f transported
animals to a large group o f animals (13S).
a. Clinical signs. Both subtypes o f equine influenza viruses produce
similar clinical signs in horses but equine 2 infections are usually more severe (1). The
first sign o f infection is an elevation in body temperature up to 41° C which is generally
biphasic (159). Fever is followed by a dry deep cough which begins a few hours to 2 days
after the elevation in body temperature. Other clinical signs may include a serous nasal
discharge which may become mucopurulent due to secondary bacterial infection, myalgia,
inappetence, and enlarged mandibular lymph nodes (1). Oedema o f the legs and scrotum
is sometimes observed and spasmodic and impaction colic is also sometimes observed (1).
Horses usually recover clinically from uncomplicated influenza within 10 days but
coughing may persist for longer than 10 days (1). Secondary bacterial infection(s)
prolongs the recovery period (1). Pneumonia has been reported in foals, horses that are
stressed by strenuous exercise, and donkeys which are more susceptible to influenza than
horses (160).
Equine 2 viruses cause pneumonia more frequently than equine 1 viruses and have
also been associated with myocarditis (159). Pregnant mares infected with EIV may abort
or resorb the fetus (1). Chronic pharyngitis, chronic bronchiolitis, alveolar emphysema,
and sinusitis have been recorded in ElV-infected animals as sequelae.
b. Vaccination. Vaccinated horses are less susceptible to EIV than
unvaccinated horses or horses that receive fewer vaccinations at an early age. Resistance
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to the disease has been shown to be closely correlated with the vaccination history and HA
antibody titers at the time o f exposure (I).
Wood and coworkers (161) demonstrated that influenza vaccine-induced
antibodies are short lived, persisting for 4-6 months. Thus, vaccination o f animals against
influenza virus is not consistently effective largely due to inability to maintain adequate
antibody titers. The propensity o f the virus to undergo drastic antigenic changes
(antigenic shift and antigenic drift) is one o f the factors which makes production o f a
consistently effective influenza vaccine difficult (81).
It is advisable to vaccinate young horses at 4-6 month intervals for several years
after their primary course o f three vaccinations (I). Annual vaccination for race horses
and competition horses is mandatory in several countries (1). The EIV vaccines that are
currently available are inactivated. Live attenuated vaccines have proved very difficult to
develop because o f the inherent mutability o f the virus. Current vaccines in North
America contain the prototype viruses A/equine 1/Prague 56 and A/equine 2/Miami 63
(162). The majority o f vaccines also contain a variant o f Miami 63 represented by
A/equine 2/Fontainbleau 79 or A/equine 2/Kentucky 81 (1). Recently, equine influenza
vaccines containing immune stimulating complexes (ISCOMs) have become available
(163). In the form o f ISCOMs, EIV proteins are highly immunogenic and it is claimed
that they stimulate a protective immune response which persists for over a year (163).
4. Lymphoproliferative Response to Vaccination and Infection
Lymphocyte blastogenic responses to influenza antigens were detected 3 to 6 days
after viral infection (164). Helper T-cell activity peaked at day 2, cytotoxic activity was
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detectable by day 4, and cytotoxic activity peaked between days 6 and 8 in mice that
received intravenous injections o f influenza virus (55). This cellular response leads to
rapid recovery from subsequent viral challenge (165).
Influenza-specific in vitro lymphoproliferation and IL-2 production by human
PBMCs were increased following vaccination (166). Saririan and coworkers (167)
demonstrated that some healthy elderly populations can be separated on the basis of
responders [hemagglutination inhibition (HAI) titer > or = 40] or non-responders to
influenza vaccination. Research from the same laboratory further demonstrated that
lymphocytes isolated from the responders 4 weeks after vaccination had a higher in vitro
proliferative response than lymphocytes from non-responders (167). Lymphocyte
proliferation to influenza A virus following live-attenuated virus vaccination o f older
chronically ill adults increased (168). Age-related decreases in T-cell proliferation have
been reported in mice inoculated with influenza A virus (169). Factors such as
prematurity, health status, and previous influenza immunization o f children plays an
important role in magnitude of T-cell proliferative responses to influenza antigen (170).
Mumford and coworkers (2) demonstrated that in vitro lymphocyte proliferative
responses in horses were stimulated after they were vaccinated with EIV vaccine. No
significant CTL activity was induced by any o f the vaccines. However, there was
significant CTL activity in previously infected ponies that were tested prior to being
challenged with EIV (H3N8). Four days after challenge infection, CTL activity was
detected in all vaccinated ponies but the highest response was measured in ponies that had
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been infected previously. Although inactivated influenza vaccines stimulated lymphocyte
proliferative responses they did not stimulate measurable CTL activity (2).
F. Effects o f Exercise Stress on Humoral and Cellular Immunity
Exercise causes an increase in circulating leukocyte numbers in humans (171). The
magnitude o f this increase is related to duration and intensity o f exercise and the increase
may be related to an increase in granulocytes (171). Circulating lymphocytes are also
increased in humans during exercise and related changes in the relative proportions o f T,
B, and NK cells as well as subsets o fT cells have been reported (171, 172). Total
leukocytes and granulocytes may remain elevated for several hours after exercise whereas
lymphocytes may fall below baseline before they return to pre-exercise levels (171, 172).
Pronounced changes in leukocytes and lymphocytes during exercise are usually
transitory and cell counts are restored to normal levels within 24 hours in humans (173).
This change may reflect redistribution o f cells between different lymphoid compartments
and not the synthesis of new cells (174). Leukocyte counts in athletes over a long term
are relatively unaffected by exercise training (171).
M oderate exercise does not appear to change resting total serum immunoglobulin
(Ig) levels (173). However, resting Ig and specific antibody levels may be decreased by
intense sport training (173). Resting Ig and specific antibody levels are restored by
reducing training after the season ends (173). Serum antibodies to specific pathogens may
be increased following exercise training o f mice (175, 176). Secretory IgA was decreased
after intense prolonged exercise in humans (177). Changes in secretory IgA were
particularly pronounced in competitive human athletes (177) and IgA levels were partially
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recovered during reduced training periods (178). These transitory changes in IgA may be
temporally related to the appearance o f upper respiratory tract illnesses including influenza
infections in elite athletes (179).
There is limited information available on how exercise effects equine immune
function. Acute maximal exercise results in leukocytosis, lymphocytosis, and a decrease in
the neutrophil to lymphocyte (N/L) ratio (132, 180). The N/L ratio is increased after 2 to
3 hours o f exercise due to a drop in lymphocytes and neutrophilia. The acute effects o f
exercise stress were reduced by training (181). After horses were subjected to intense
exercise stress on a treadmill, phagocytic activity o f alveolar macrophages was depressed
for up to 3 days (126, 134) and impaired blood neutrophil chemotaxis and oxidative
metabolism was measured for 1 day after exercise (135).
There are conflicting reports about the effects o f exercise on lymphocyte responses
to mitogens. Wong and coworkers (135) reported that lymphocyte function was not
altered by intense exercise in horses. Further, they reported that B-cell activity and serum
IgM, IgG, and IgA was not affected by exercise. One other study demonstrated a
suppression o f the proliferative response to Concavalin (Con) A and phytohemagglutinin
(PHA) mitogens following a 30 minute treadmill exercise bout (125). Horohov and
coworkers (123, 131) reported exercise-induced changes in equine influenza specific
lymphoproliferation and lymphokine activated killer (LAK) cell activity. Acute exercise
challenge o f unconditioned horses decreased PWM and EIV type 2-induced
lymphoproliferation during and after exercise (123). Training o f the horses modified the
effects o f acute exercise stress on immunological functions and the effects of various
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hormones and amines on lymphoproliferation (123). Equine LAK cell activity was
increased during exercise (123). This increase in LAK ceil activity has been attributed to
increased responsiveness o f cells to interleukin-2 (IL-2) rather than to an increase in IL-2
receptor number or an increase in the number of LAK cell precursors (122).
G. Closing Remarks
Horses that are stressed are more susceptible to disease. All stressors are related
to release o f glucocorticoid and catecholamines. However, very little is actually known
about the relationship between stress-induced changes in cortisol and catecholamines and
the effect that these compounds have on equine immune function. Experiments
summarized in this dissertation were done to begin to address this deficiency.
The experiment described in Chapter four was done to determine whether equine
PBMCs have detectable GR. This experiment also characterized diurnal changes in
subcellular localization o f GR in order to begin to identify time points when nuclear GR
may be present to interact with GREs or interfere with other second messenger systems.
The experiment described in Chapter five was done to characterize the effect of
various stressors on catecholamine concentrations in the circulation. Lymphoproliferation
induced by mitogens and EIV was tested for samples collected during the same stress
tests. This was done to determine whether acute changes in circulating catecholamines
concentrations were related to stress-induced changes in lymphoproliferation.
Chapter six summarizes results from experiments which tested in vitro effects of
norepinephrine, epinephrine, and adrenergic agonists on proliferation o f equine PBMCs
collected from resting horses. The objective o f these experiments was to clarify our
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understanding o f catecholamine effects on equine PBMCs. Use o f various agonists was
expected to provide preliminary information on the type o f adrenergic receptor and related
second messenger which may be involved in adrenergic effects.
The last experiment was done to measure cortisol and lymphoproliferation at
various time points in chronically stressed and unstressed ponies. This experiment was
done to determine if there was a relationship between hormone secretion and
lymphoproliferation.
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CHAPTER m : MATERIALS AND METHODS
This chapter describes experimental subjects and methods used throughout the
project. The project included four different experiments which were started in the summer
of 1992 and completed in the fall o f 1994. Each experiment is discussed in a separate
chapter. Details regarding materials and methods used only in an individual experiment
will be described in the related chapter.
A. Animals
These experiments included seven horses and eight ponies. The first part o f the
project included horses as experimental subjects and the last experiment used ponies. The
materials and methods for horses, and assays used to assess experimental endpoints in
both horses and ponies, are described in this chapter. Details pertinent only to materials
and methods which apply to ponies are described in Chapter seven. Use o f horses and
ponies for these experiments was reviewed and approved by the Louisiana State
University Institutional Animal Care and Use Committee.
1. Treadmill conditions
A Mustang 2200 high performance equine treadmill (Kagra Intl. Inc., Fahrwangen,
Switzerland) was used for acclimation, psychological stress tests, and exercise stress tests.
Heart rate was assessed during exercise stress tests using an on board heart rate monitor
(Hippocard PEH2000, Bioengineering, Zurich, Switzerland). Speed and incline o f the
treadmill was controlled manually and the treadmill system was maintained in an enclosed
room.

41
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2. Horses
Thoroughbred horses were used during the course o f tiiis study. These horses
were trained and handled as race horses prior to being donated to the university. Horses
were maintained on pasture and fed 10 quarts o f Omalene pellets (Purina Mills, St. Louis,
MO) at 8:00 AM and 4:00 PM. W ater was supplied ad-libitum. All horses were
vaccinated intramuscularly with inactivated influenza A/equine/H3N8 and influenza
A/equine/H7N7 strains (Fort Dodge, IA). Each horse received 2 vaccinations, 14 days
apart, as recommended by the manufacturer. Vaccines were administered by a licensed
veterinarian on an annual basis in the month o f January and resident veterinary care
provided regular deworming and farrier work throughout the project. The age, sex, and
order of experimental procedures performed on the horses are summarized in Table 1.
The horses were 6 to 11 years old at the beginning o f the experiments. There were
four mares and four geldings. Geldings were castrated at least two years before they were
included in the project. Horses were used for experiments performed from June o f 1992
until July o f 1993.
Two o f the horses (#102 and #20) were dropped from the project after the
experiments were started due to the development o f health problems or injury. Horse
#102 was included only in the minimal exercise stress test and was not used further due to
a leg injury. Horse #20 was excluded from the last exercise stress test due to health
problems. Finally, horse #108 and #135 had been used in exercise conditioning
experiments performed in 1991. These two horses were included in the present study
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Table 1: Age, Sex, and Order o f Experimental Procedures Performed on Horses

Horse identification #
#16

#20

#59

#83

#102

#108

#135

#138

Sex

M

G

M

M

G

G

G

M

Age (yrs)

S

11

7

7

11

11

7

6

Vac (1/91, 92, 93)

X

X

X

X

X

X

X

X

Accl (3/92)

X

X

X

X

X

X

X

X

RA (6/92)

X

X

X

MES(2/93)

X

X

X

X

X

X

X

SG (2/93)

X

X

X

X

X

X

X

SS (3/93)

X

X

X

X

X

X

X

SP (3/93)

X

X

X

X

X

X

X

FG (5/93)

X

X

X

X

X

X

X

X

X

X

IV (6/93)

X

X

This table gives a brief account o f experimental details pertinent to the use o f horses in the
project. Dates o f the various stress tests, immunological assays, endocrine assays, and
receptor binding assays are listed chronologically. Horse identification numbers are listed
in the top row. Sex o f the animal is indicated by M (mare) or G (gelding). The age for
each horse corresponds to the age at the beginning o f the experiments (1992). Presence
o f a x in the box indicates that the horse was used in a particular experiment. A blank box
indicates that a horse was not included in an experiment. Vac = vaccination, Accl =
acclimation period, RA = cortisol receptor assay; SS = sham/stalled stress, SP =
sham/psychological stress, MES = minimal exercise stress, SG = slow gallop/moderate
exercise stress, FG= fast gallop/intense exercise stress, IV = in vitro analysis o f
lymphoproliferation in the presence o f native catecholamines and catecholaminergic
agonists.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

since they appeared unconditioned based on various physiological parameters including
exercise-induced changes in heart rate, blood lactate, and in vitro lymphoproliferation.
Each horse was subjected to an acclimation period. During this period the horses
walked and trotted on the treadmill. Horses were subjected to five different stress tests
which included a sham/stalled, sham/psychological, minimal exercise, slow
gallop/moderate exercise, and a fast gallop/intense exercise test. The sham/stalled stress
test was done to obtain baseline data for various experimental endpoints. This test was
performed on horses that stood in box stalls. This test was started at 6:00 AM and ended
at 9:00 AM. Two to three horses were tested per day, so that it took three days to
complete the test.
The sham/psychological stress test was performed where horses stood on a
stationary treadmill. The horses anticipated exercise, as they were acclimated to regular
exercise on the treadmill. The sham/psychological stress test was done to see if anxiety
related to anticipation o f exercise had any effect on our experimental endpoints. The tests
were started at 6:00 AM and the last sample from the last horse was collected at 10:00
AM.
The minimal exercise stress test utilized a protocol where horses were walked on
the treadmill for 2 minutes at 2 meters (m)/second (s), trotted for 3 minutes at 4 m/s, and
walked for 3 minutes at 2 m/s. The minimal exercise stress test was done to determine
whether low-level physical exertion effected our experimental endpoints. The tests were
started at 6:00 AM and they ended at 10:00 AM when the last sample was collected from
the last horse.
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The slow gallop/moderate exercise stress test consisted o f a 2 minute walk at 1.5
m/s, a 3 minute trot at 3.5 m/s, a 3 minute gallop at 8 m/s, a 5 minute gallop (8 m/s) on a
7% incline, and a 2 minute trot at 3.5 m/s. This test was done to determine whether an
increase in exercise intensity would lead to significant changes in endocrine and
immunological endpoints. The tests were started at 6:00 AM and ended when the last
sample was collected from the last horse at 10:00 AM on each day o f the stress test.
Finally, a fast gallop/intense exercise stress test was performed where horses were
walked for 2 minutes at 1.5 m/s, followed by a 3 minute trot at 3.5 m/s, a 3 minute gallop
at 10 m/s, a 5 minute gallop (10 m/s) on a 7% incline, and a 2 minute trot at 3.5 m/s. The
tests were started at 6:00 AM and completed by 10:00 AM on each day o f the experiment.
This stress test differs from the slow gallop/moderate exercise stress test since the gallop
speed was increased by 2 m/s. The fast gallop/intense exercise stress test was performed
since the slow gallop/moderate exercise stress test did not significantly elevate heart rate
or alter immunological endpoints.
The minimal exercise and slow gallop/moderate exercise stress tests were
performed in a Latin square cross-over design. Sham/stalled stress and
sham/psychological stress tests were also performed in a Latin square cross-over design
whereas the fast gallop/intense exercise stress test was the last experiment that used the
horses. Dates that specific animals were used in each stress test are listed in Table 2.
Pre-test handling was the same for all the horses. Specifically, horses were housed
in box stalls overnight before each stress test. They were fed and watered for the day
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T ab le 2: Dates and the Specific H orses Used in Each Stress Test

Stress tests
Sham/stalled

Minimal exercise
stress

Slow gallop/
moderate
exercise stress

2/1/1993
through
2/4/1993

Horse #
16, 59, 102, 108

Horse #
20, 83, 135, 138

2/15/1993
through
2/18/1993

Horse #
20, 83, 135, 138

Horse #
16, 59, 108

Dates

Sham/
psychological

3/16/1993
through
3/18/1993

Horse #
20, 83, 135, 138

Horse #
16, 59, 108

3/29/1993
through
3/31/1993

Horse #
16, 59, 108

Horse #
20, 83, 135, 138
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before each stress test. On the day o f the stress test, food and water were withheld until
the last sample was collected.
Each horse spent about 25 minutes on the treadmill during the sham/psychological
or exercise stress tests. All horses that were subjected to exercise stress were washed and
allowed to cool down for about 15 minutes after they got off the treadmill. They were
stalled until the last sample was collected from all o f the horses in the test.
B. Blood Sample Collection and Analysis
Blood was collected during each o f the exercise and sham stress tests and when
animals were in their stalls or on pasture. All blood samples were aseptically collected
into vacutainer tubes (Becton Dickinson, Rutherford, NJ). Multiple sample 18 G needles
were used to collect blood samples by jugular venipuncture from the resting animals in
their stalls or on pasture. Blood samples from the animals subjected to the exercise stress
or sham stress tests were collected via an indwelling jugular catheter. Blood samples were
used to quantitate cortisol and catecholamines in the plasma and serum, respectively.
Glucocorticoid receptors in peripheral blood mononuclear cells (PBMCs) were measured
using blood samples collected from horses. Immunological assays included measurement
o f pokeweed mitogen (PWM), phytohaemagglutinin (PHA), and equine influenza virus
(ElV)-induced lymphoproliferative responses o f PBMCs recovered from the blood
samples collected from horses and ponies.
1. Immunological Assays
Blood samples for immunological assays were aseptically collected into 20 ml
heparinized (10 U/ml o f blood) vacutainer tubes (Becton Dickinson). Sampling time
points will be discussed for each individual experiment.
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a. Recovery o f PBMCs. Vacutainer tubes were centrifugated at 750 x g
for 10 minutes to obtain bufiy coats. Buffy coats were diluted in 30 mis o f calcium and
magnesium-free phosphate buffered saline (CMF- PBS; 0.01 M sodium phosphate, 0.9%
NaCl, pH=7.4). This suspension was layered onto 10 ml o f Ficoll-Paque (Pharmacia LKB
Biotechnology, Piscataway, NJ) and tubes centrifuged at 600 x g for 30 minutes. The
Ficoll-PBS interface o f PBMCs was collected. Peripheral blood mononuclear cells were
resuspended in CMF-PBS and pelleted by centrifuging at 600 x g for 10 minutes and twice
at 150 x g for 10 minutes after the pelleted cells were resuspended in CMF-PBS.
Peripheral blood mononuclear cells were counted on a hemocytometer for further analysis.
b. Mitogen-induced lymphoproliferation. Triplicates or quadruplicates o f
2 x 10s PBMCs/well were incubated in a final volume o f 0.2 ml in 96 well round bottomed
plates (Coming Glass Works, Coming, NY). Cells were incubated with 2 ug PWM
(GEBCO/BRL, Gaithersburg, MD) or 2 ug PHA (GIBCO/BRL) per ml of culture media.
The plated cells were incubated at 39° C with 5% CO, for 5 or 7 days. Controls included
PBMCs diluted in RPMI 1640 media (GEBCO/BRL) supplemented with 5% (v/v) horse
serum (Atlanta Biologicals, Atlanta, GA), 1% (v/v) glutamine (GEBCO/BRL), 1% (v/v)
10,000 U/ml pencillin, 1% (v/v) 10 mg/ml streptomycin (Pfizer, New York, NY), 20mM
HEPES (Sigma Chemical Co, St. Louis, MO), and 2 x l0 ‘7 M 2-mercaptoethanol (Sigma
Chemical Co). Cultures were incubated with 0.5 pCi 3H-thymidine (New England
Nuclear, Boston, MA) for 4 hours on days 5 or 7. Peripheral blood mononuclear cells
were harvested onto glass fiber filter paper and counted in a liquid scintillation counter
(Pharmacia LKB Biotechnology). Lymphoproliferation was recorded as the stimulation
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index. The stimulation index was calculated by dividing the counts per minute (cpm)
measured for mitogen treated cells by the cpm measured for unstimulated cells from the
same horse (media control).
c.

Equine influenza virus-specific lymphoproliferation. Equine influenza

virus A (type 2) was propagated in embryonated chicken eggs and harvested allantoic fluid
was stored at -70° C until use. This EIV stock contained 160 hemagglutination (HA)
units (U) per ml.
Replicates o f 2 x 10s PBMCs/well were incubated with 1.6 HA U (dose 1) or 16
HA U (dose 2) for 5 or 7 days. Media used in the assay was the same as that for the
mitogen-induced lymphoproliferation studies. Controls included PBMCs and media. The
final volume in each well was 0.2 ml and cultures were incubated at 39° C and with 5%
C 0 2. On days 5 and 7 o f incubation, PBMCs were incubated with 0.5 pCi o f 3Hthymidine for four hours. Cells were harvested onto glass fiber filter paper and counted in
a liquid scintillation counter. Specific lymphoproliferation was recorded as the stimulation
index.
2. Hormone Assays
All blood samples for cortisol quantitation were collected into 10 or 20 ml
heparinized Vacutainer tubes (Becton Dickinson). Blood samples used for catecholamine
assays were collected into 7 ml EDTA Vacutainer tubes (Becton Dickinson) after 100 pi
o f a 420 mg/ml glutathione (Sigma Chemical Co.) solution was added to each tube.
Sampling time points will be discussed separately in individual chapters.
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a.

Cortisol radioimmunoassays. Blood samples were centrifuged at 750 x

g, for 10 minutes, immediately following collection. Plasma was pipetted into
microcentrifuge tubes as 1.5 ml aliquots which were snap frozen on dry ice. Samples were
stored at -80° C until the time o f radioimmunoassay (RIA).
One hundred microliter aliquots o f the thawed plasma samples were extracted with
2 mis o f acetone (ACS, PVC, CTD, Mallinckrodt Inc., Paris, Kentucky). The extracts
were dried and then reconstituted in 500 pi ofPBS-gelatin (PBS-Gel; 0.01 M sodium
phosphate, 0.9% NaCl, 0.097% NaN3, 0.1% gelatin; pH=7.3). Triplicate 100 ul aliquots
o f the reconstituted extracts were assayed. The cortisol antiserum (LSU-R17) was a gift
from Dr. Donald Thompson, Jr. (Louisiana State University, Baton Rouge, LA). This
antibody has been characterized and validated for analysis o f equine samples (133).
Assays were done as described by Thompson and coworkers (133) using tritiated cortisol
(specific activity 1.0 mCi/ml; Dupont, MD) as the radioactive ligand (24,000 cpm/tube).
A standard curve was generated by graphing results for 9 serially diluted cortisol (Sigma
Chemical Co.) standards ranging from 6000 to 31.25 pg/ml. Replicate low (75 pg/100 ul)
and high (225 pg/100 ul) internal standards were run to check the accuracy o f the assay
and to calculate inter- and intra-assay variation. Non-specific binding was tested with
PBS-Gel.
Radioimmunoassay tubes were incubated at 4° C for 24 hours. Radioactive
cortisol was quantitated after absorbing unbound cortisol with charcoal. This was done by
incubating each tube with 500 ul o f 1% (w/v) neutralized, activated charcoal in PBS-Gel
and centrifuging the assay tubes at 3000 rpm for 10 minutes. The resulting supernatant
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was mixed with 2.5 mis o f liquid scintillation cocktail (Ultima Gold™, Packard Instrument
Company, Meriden, CT) and radioactivity was measured in cpm on a Packard liquid
scintillation counter.
b.

Catecholamine assay. Catecholamines in equine blood samples were

measured as previously described by our laboratory (127). Briefly, blood samples were
centrifuged at 750 x g for 10 minutes immediately after their collection. Serum was
pipetted into microcentrifiige tubes as 1.5 ml aliquots and snap frozen on dry ice. Serum
samples were stored at -80° C for subsequent analysis. Samples were thawed to room
temperature and 100 pi o f serum was diluted with 300 pi o f running buffer. The running
buffer included 3.35g monocholoroacetic acid, 5.3g NaH2P 0 4H20 , and 0.5g sodium
dodecycl sulphate dissolved in 720 ml deionized distilled water, 200 ml acetylnitrile, and
80 ml methanol. Buffer was adjusted to a pH o f 3.0-3.5. This buffer was filtered twice
through 0.22 pm pore size filters (Millipore Corporation, Bedford, MA). Diluted samples
were then filtered through non-sterile Ultra ffee-MC filter units (MW c.o=5000, # uF
C3LCCOO, Millipore Corp.). The sample filtrate was stored at 4° C until monoamine
quantification.
Monoamines were resolved by high performance liquid chromatography (HPLC).
A Hewlett Packard 1090 liquid chromatograph with an absorbosphere Clg reverse phase
column (Alltech Associates, Inc., Deerfield, EL), protected by a guard column (VYDAC
201 IP Clg 300A), was used for HPLC. A single Hewlett Packard 1049A electrochemical
detector, set at 700 mV, was used to resolve amines. The running buffer described in the
preceding paragraph was used as the mobile phase. Retention times for norepinephrine
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and epinephrine were approximately 5 and 10 minutes, respectively. Three, fourdihydroxybcnzyiamine hydrobromide (Sigma Chemical Co.) was used as an internal
standard.
C. Statistical Analysis
All assays were done with triplicate or quadripulicate replications o f each sample
A statistical analysis system (SAS) on a personal computer and on the university main
frame computer were used for each analyses. P-values o f <0.05 were considered
significant for all assays. Specific statistics that were used to analyze results from
individual experiments will be described in the related chapters.
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CHAPTER IV: DIURNAL CHANGES IN SPECIFIC BINDING OF CORTISOL
TO CYTOSOLIC AND NUCLEAR FRACTIONS FROM EQUINE PERIPHERAL
BLOOD MONONUCLEAR CELLS

A. Introduction
Stress is related to release o f multiple hormones and neurotransmitters and it has a
wide range o f effects on the immune system. A particular stressor may increase leukocyte
concentrations, alter the peripheral distribution o f leukocytes, produce lymphopenia,
decrease helper cell subsets, increase monocyte populations, increase natural killer (NK)
cell activity, decrease immunoglobulin concentrations, decrease interleukin (IL)-l
secretion, increase IL-6 secretion, and increase killing o f NK cell resistant targets by
lymphokine activated killer (LAK) cells (83, 182 - 184).
Glucocorticoids effect almost all eukaryotic cells due to the wide-spread
distribution o f the related receptor (75) and high concentrations o f these steroids have
potent inhibitory effects on various immune functions (185). Hormone binding to
glucocorticoid receptors (GR) activates the receptor and increases its affinity for
chromatin (75). Hormone-bound GR binds to glucocorticoid response elements (GREs)
which regulate transcription of various genes. Glucocorticoid effects may also involve
binding to GREs that overlap binding sites for cAMP responsive element binding protein
(CREB); thereby preventing the effectiveness o f cAMP cascades. Hormone occupied GR
may also bind to subunits o f activator protein-1 (A P-l) which blocks the transcription o f
genes that are dependent on stimulation by AP-l nuclear proteins (76, 77). Molecular
interactions between multiple signaling systems is a contemporary research area that is
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likely to be important to our general understanding o f neuroimmunology and clinical
management o f stress-dependent reductions in various immune functions. Characterizing
the time points when GR are available for interactions with other nuclear proteins will
provide a basis for subsequent experiments on cross-talk between GR and other second
messengers.
The equine species exhibits diurnal fluctuations in plasma cortisol concentrations
(13, 73). These hormone fluctuations are likely to result in alterations in hormoneoccupied GR that are available for interactions with GREs and various nuclear proteins.
This possibility is supported by diurnal fluctuations of GR in human and rat peripheral
blood mononuclear cells (PBMCs) (186). Similar studies have not been reported for the
equine species.
Cortisol binding to GR in cytosolic and nuclear fractions o f equine PBMCs was
measured in this experiment in order to gain a better understanding o f receptor dynamics
and verify that specific GR are present in equine PBMCs. Changes in subcellular
concentrations of GR may be of particular interest in light o f diurnal fluctuations in
cortisol secretion as well as differences in the hormonal and immunological response
during morning and evening times o f the day (4, 73).
B. Materials and Methods
I. Horses
Four unconditioned horses were used for this experiment. The description and
maintenance o f these horses were specified in Chapter three.
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2. Sample Collection and Fractionization o f Nuclear and Cytosolic Protein
a. Sample collection. Blood samples were collected aseptically into 20 ml
heparinized (10 U/ml o f blood) Vacutainer tubes (Becton Dickinson., Rutherford, NJ) by
jugular venipuncture from resting horses. Horses were on pasture when samples were
collected to validate the cortisol receptor assays. Samples collected at 8AM and 2PM
were used to validate assays. Samples were subsequently collected at six hour intervals
(8 AM, 2PM, 8PM, 2AM) in order to measure any diurnal variations o f cortisol binding to
nuclear and cytosolic fractions. Horses were housed in open air stalls when blood samples
were collected at 6 hour intervals.
The PBMCs were recovered as described in Chapter three. Cells were washed
with 5 ml o f ice cold TEMGD buffer [10 mM Tris, 1.5 mM EDTA, 25 mM molybdate,
10% (v/v) glycerol, and 1 mM dithiothreitol (pH =7.4)]. Centrifugation was used to
recover cell pellets and pelleted samples were snap frozen and stored at -85°C.
b. Fractionization o f nuclear and cytosolic protein. Pelleted cells were
suspended in 1 ml o f ice-cold TEMGD buffer per 6.0 x 107 cells. The PBMCs were
briefly homogenized with a polytron and homogenates were centrifuged at 700 x g and
4°C for one hour. The resulting supernatants were used to measure specific binding to
cytosolic fractions. Pellets from homogenized PBM Cs were diluted in 1 ml o f ice-cold
TEMGD buffer per 6.0 x 107 cells. This fraction was used for contemporary analysis o f
binding to nuclear GR.
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3. Validation o f Receptor Binding Assays
Initial binding studies were based on commonly used steroid receptor assays
previously tested by our laboratory to analyze estrogen and progesterone receptors (187).
Preliminary experiments characterized: (a) time-dependent specific binding o f radiolabeled
cortisol to cytosolic preparations; (b) saturation o f specific binding with variable
radioligand concentrations; (c) linear binding to different protein concentrations; and (d)
loss o f specific binding in heat-treated samples.
a.

Time-dependent specific binding o f radiolabeled cortisol to cytosolic

preparations. Fractions from 6.0 x 107 PBMCs were incubated with 500 fmoles (fM) o f
tritiated cortisol (specific activity lpC i/pl, New England Nuclear, Boston, MA) in the
presence or absence o f 1000 nM dexamethasone (Sigma Chemical Co., St. Louis, MO).
Reagents were diluted in TEMGD buffer. Assay volume was standardized to 400 pi with
TEMGD buffer and tubes were incubated at 4°C. Specific and non-specific binding were
measured at 0, 5, 10, 15, 20, 25, and 30 hours after the beginning o f incubation. Unbound
hormone was removed by incubating samples with 400 pi o f 1% (w/v) charcoal in PBSgel (0.005 M mono and 0.005 M dibasic sodium phosphate, 0.9% NaCl, 0.2% gel, pH
7.4) for 15 minutes at 4°C. Samples were subsequently centrifuged (700 x g) for 20
minutes at 0° C. Bound radioactivity in the resulting supernatant was counted on a
Packard liquid scintillation counter after mixing samples with 2.5 ml o f Ultima Gold
scintillation cocktail (Packard Instrument Co., Meriden, CT). The assay also included two
sets o f tubes containing 300 ul o f TEMGD buffer and 500 fM o f tritiated cortisol. One set
was processed to separate bound and unbound hormone for purposes o f determining the
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non-specific binding. The second set was used to determine total radioactivity. The cpm
measured for each sample were calculated as fM bound per 10s PBMCs. This was
possible since radiolabeled cortisol added to each assay tube contained a known number o f
moles. Total and specific binding were plotted to evaluate binding at various time points.
b. Saturation o f specific binding with variable radioligand concentrations.
Saturable-specific receptor binding was demonstrated by incubating protein from 6.0 x 107
PBMCs with 156.35, 312.50, 625, 1250, 2500, or 5000 fM o f tritiated cortisol in the
presence or absence o f excess unlabeled dexamethasone. The volume in each tube was
brought up to 400 pi with TEMGD buffer. Assays were incubated at 4°C for 10 hours.
Bound and unbound fractions were separated as described above. Radioactivity in the
supernatant was plotted to evaluate linear and saturable binding. Intra- and inter-assay
variation were less than or equal to 10%.
c. Linear binding to different protein concentrations. Linear binding was
tested using 25, 50, 75, 100, 150, and 200 ug o f protein from PBMCs. Protein
concentrations were measured using the Pierce micro BCA protein assay reagent kit
(Pierce, Rochford, IL) and standard protocols described by the manufacturer. Protein
concentrations in each tube were prepared from 1.0 x 106 to 1.0 x 10* PBMCs. Cytosolic
protein fractions were incubated at 4°C for 10 hours with 500 fM o f tritiated cortisol.
Replicates were incubated with and without 1000 nM dexamethasone. Free and bound
hormone separation was performed as mentioned above. Plots o f results for each horse
were evaluated separately. An internal standard prepared from a pool o f PBMC extracts
was used to evaluate assay variability which was less than 10%.
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d.

Loss o f specific binding in heat-treated samples. Heat lability o f

receptor protein was confirmed by heating cytosolic fractions from 6.0 x 107 PBMCs to
60°C for 15 minutes. Untreated replicate cytosolic fractions were tested for binding as a
contemporary control. Triplicate aliquots o f control and heat treated cytosolic protein
were incubated with 3500 fM o f tritiated cortisol in the presence or absence o f excess
dexamethasone. Samples were incubated at 4° C for 10 hours. Separation o f bound and
free hormone was done as described above.
4. Diurnal Variation o f Cortisol Binding to Nuclear and Cytosolic Fractions
Samples from 4 horses were assayed in triplicate. The assay volume was 400 ul
per tube which included 3500 fM o f tritiated cortisol and 100 ul o f cell protein extracted
from 6.0 x 106 PBMCs and suspended in TEMGD buffer. The number o f cells used was
based on the cell number which consistently yielded protein concentrations that exhibited
linear specific binding to radiolabeled cortisol. Samples were incubated at 4° C for 10 hrs.
Free and bound hormone were separated as described above. Specific binding was
measured as radiolabeled cortisol displaced by 1000 nM dexamethasone. Specific binding
is expressed as fM o f hormone bound based on known molar concentrations o f radioactive
hormone in contemporary total count tubes. Data for the samples were standardized as
fM specifically bound per 106 PBMCs. These values were analyzed by one way ANOVA
and pairwise comparisons were done using LSD.
C. Results
Validation assays demonstrated time-dependent, saturable-specific binding that
was abolished by heat treatment o f the receptor fractions. Specific binding to protein
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incubated for various time periods (Figure 7) increased from 0 (0.002 fM/106 cells) to 5
(0.050 fM/106 cells) hours and from 5 to 10 (0.070 fM/106 cells) hours. Binding in
fractions incubated for 15 (0.020 fM/ 106 cells), 20 (0 fM/106 cells), 25 (0 fM/106 cells),
and 30 (0 fM/106 cells) hours was markedly reduced.
Linear binding was demonstrated for protein concentrations ranging from 75 to
200 pg (Figure 8). Specific binding to 75, 100, 150, and 200 pg was 2.32, 5.70, 8.40, and
12.3 fM respectively. Regression analysis o f the data demonstrated a positive linear
relationship (P = 0.0024; R2 = 0.9214) When linear binding was evaluated for PBMCs
collected at various time-points and from different horses (n=4), protein concentrations o f
100, 150, and 200 ug consistently exhibited linear binding. This amount o f protein was
recovered from 4.5 x 106 to 1.0 x 10* PBMCs.
Saturable specific binding was observed when tubes were incubated with 2500 to
5000 fM of radiolabeled cortisol (Figure 9). However, the amount o f hormone bound
represented a small fraction o f the radiolabeled hormone concentration. Cells incubated
with 156.35, 3 12.50, 625, 1250, 2500, or 5000 fM o f tritiated cortisol bound 0.037,
0.020, 0.060, 0.070, 0.150, and 0.160 fM of cortisol per 106 PBMCs, respectively.
Binding to control fractions (0.05 fM/106 PBMCs) was abolished (0 fM/106 PBMCs)
when replicates were heated to 60° C for 15 minutes.
Table 3 lists specific binding (mean + SE) to nuclear and cytosolic fractions and
total binding for samples collected at various time points. Binding to the cytosolic fraction
was lower (P<005) at 8AM than binding to samples collected at 2PM. Binding at 8AM
was also lower (P<.025) than binding to cytosolic fractions prepared from cells collected
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Figure 7: Time dependent binding of radioactive cortisol to PBMC fractions.
Protein fractions from 6.0 x 107 PBMCs were incubated with tritiated cortisol in the
presence or absence o f excess dexamethasone. Specific and non-specific binding were
measured at 0, 5, 15, 20, 25, and 30 hours o f incubation.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

61

Protein (jig)

Figure 8: Linear binding of radiolabeled cortisol to PBMC fractions. Protein
concentrations were prepared from 1.0 x 106 to 1.0 x 10s PBMCs. Fractions were
incubated with and without excess dexamethasone. Regression analysis was used to
determine that there was a linear relationship between binding and protein concentrations
ranging from 75 to 200 pg.
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Figure 9: Saturable specific binding of cortisol to PBMC fractions. Saturable
specific binding was demonstrated by incubating protein from 6.0 x 107 PBMCs with
tritiated cortisol in the presence or absence o f excess unlabeled dexamethasone. Specific
binding was abolished when cell fractions were heated to 60° C for 15 minutes as
compared to binding measured for controls. Specific binding was saturated for protein
concentrations ranging from 2500 to 5000 fM.
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Table 3: Specific Binding of Radiolabeled Cortisol to PBMC Fractions
Collected Throughout the Day
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Time of the day

Cytosolic receptor
binding

Nuclear receptor
binding

Total binding

8 AM

0.50 ± 0.40*

10.10 ± 4.91

10.60 ± 2.31

2 PM

6.45 ± 0.051’

12.70 ± 9.93

19.15± 4.21*

8 PM

5.70 ± 1.56h

6.10 ± 0.12c

2 AM

8.10 ± 1.34"

0.00 ± 0.00d

11.80 ± 0 .6 7
8.10 ± t.56r

M e a n s (± S E ) w ith in a c o l u m n tha t a r e la b e le d w i th d iffe re n t le tt e r s o f a p a ir (a, b; c, d; e , 0 a r e s ta tistic a lly ( P < 0 . 0 5 ) d iffe re n t.
M e a n s w i t h o u t l e t te r s u p e r s c r i p t s w e r e n o t sig n ific a n tly d iffe re n t f ro m o t h e r m e a n s w ith in a c o lu m n .
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at 8PM and 2AM. Binding to nuclear fractions was higher (P<0.05) at 8 PM than at
2AM. Total binding was higher (P<0.05) at 2PM than binding to samples collected at
2 AM. Total binding at 8AM, 8PM, and 2AM was approximately 50% o f that measured
for PBMCs collected at 2PM.
D. Discussion
Steroid receptors available for hormone binding are believed to be associated with
the outer nuclear membrane (75). These receptors end up in cytosolic fractions when cells
are prepared for standard steroid receptor assays. Hormone-occupied steroid receptors
interact with various nuclear proteins (76, 188). Thus, it is o f interest to determine
whether nuclear GR is present in immune cells when plasma concentrations o f cortisol are
reduced. In the case o f the equine species, cortisol peaks in the early morning hours
between 8 and 10 AM (13, 73). It subsequently declines and reaches low levels during the
night. In the present study, we were unable to detect GR in nuclear fractions collected at
2 AM. This was true for all horses. It suggests that stimuli which act through cAMP
and/or protein kinase pathways would not be subject to dampening effects o f nuclear GR
in the early morning hours. On the other hand, it has not been determined how much
glucocorticoid is needed for net effects on transcription in equine PBMCs. Thus, it is not
clear whether nuclear GR found at 8 PM is active in this regard. Peak specific binding of
cortisol to nuclear GR at 8 AM and 2 PM suggests that these time points are likely to be
related to glucocorticoid-dependent protein synthesis by equine PBMCs. This assumption
is supported by glucocorticoid effects on protein synthesis in PBMCs for other species
(189). Equine immune cell proteins regulated by glucocorticoids have not been isolated.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

65
Cytosolic GR measured in the present study was low when cortisol concentrations
peak in equine plasma. Specific binding to cytosolic fractions increased throughout the
day. This would be expected based on the shuttling o f steroid receptors that occurs
following increased plasma concentrations o f steroid and steroid binding to the receptor
(186). It is also consistent with diurnal changes in GR receptor binding reported for
rodent and human PBMCs (186).
Total binding o f cortisol to equine PBMCs peaked at 2 PM. High concentrations
o f nuclear GR were found at the same time and cytosolic GR at 2 PM was higher than that
at 8 AM. However, total binding at 8 AM, 8 PM, and 2 AM were similar. This implies
that early morning increases in cortisol, and the related translocation o f GR to the nucleus,
may also stimulate GR synthesis. Glucocorticoids have been reported to up-regulate their
receptors in certain cells from humans (190). Whether this occurs in equine PBMCs will
require further study.
Results for rats and humans have indicated that immune cell GR is identical to that
found in other tissues (186). Nuclear protein extracts from equine PBMCs contain a
protein with a molecular weight comparable to GR in other species and the protein from
equine PBMCs specifically binds monoclonal antibodies directed against conserved DNA
binding sequences in GR (73). This would suggest that structure o f GR in the equine
species is similar to that which has been characterized for other species. However, it
should be noted that the time-dependent binding demonstrated in the present study was
rather unexpected. Peak binding occurred after 10 hours for fractions o f equine PBMCs.
Thereafter, it seemed that the receptor was rapidly broken down. Similar studies with
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progesterone and estrogen receptors have indicated that optimal binding is usually
observed at 15 to 18 hours when assay conditions are similar to those used in the present
study (187). This time is fairly standard for steroid hormone receptor assays. Why the
binding o f cortisol to equine PBMCs appears to be more labile is not known. However, it
may be that modifications added for processing large numbers o f samples necessary for
this experiment and related impurities in the cytosolic fractions contributed to enzymatic
degradation o f GR. The same factors may explain why such small amounts o f cortisol
were bound to fractions from equine PBMCs.
In many cell types biological effects o f glucocorticoids depend on the number of
receptors and their responsiveness to glucocorticoids (185). In humans and other species,
different stressors, including exercise stress, induce a significant decrease in GR binding
capacity (185). This suggests that target cell responsiveness to glucocorticoids may
decrease after stress due to a reduction in GR synthesis, increased degradation o f GR,
and/or inhibition o f receptor activation. In order to elucidate mechanisms responsible for
stress-induced effects o f glucocorticoids, the kinetics o f GR in various physiological
conditions needs to be more clearly defined. Published literature (185, 186), and results
from the present experiment, suggest that multiple regulatory processes probably function
to control the amount o f available GR in various cellular compartments.
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CHAPTER V: RELATIONSHIP BETWEEN EXERCISE-STRESS-INDUCED
CHANGES IN LYMPHOPROLIFERATION AND CIRCULATING
CATECHOLAMINE CONCENTRATIONS IN HORSES

A. Introduction
Research on neuroendocrine-immune interactions has indicated that diverse
stressors alter immunological functions (4, 9, 52, 119, 182, 191 - 193). The effect of
exercise on the immune system varies with the type, duration, and intensity o f physical
exertion (171, 191). Intense exercise effects a variety o f immune functions. Changes in
function o f the immune system following intense exercise stress reportedly include
decreased T and B cell responses to mitogenic stimulation, alterations in CD4:CD8 ratios,
and alterations in natural killer (NK) cell activity (171). A moderate exercise program
decreased mitogen-induced proliferation in laboratory mice (191). Immunomodulation
resulting from moderate exercise has been related to stress-dependent catecholamine
release in humans (194). Such catecholamine release probably plays a major role in
initiating immune changes by acting through adrenergic receptors (21, 84).
Inhibition o f T-cell proliferation depends on circulating concentrations o f
catecholamines after exercise and the number o f adrenergic receptors on human
lymphocytes (190). Catecholamine concentrations depend on the duration and type of
stress experienced by human subjects, but the largest increase in catecholamine release
occurred after strenuous work (190). Increased catecholamine concentrations after
submaximal bicycle exercise have been associated with increased numbers o f granulocytes,
lymphocytes, NK cells, and B cells, as well as changes in lymphocyte subsets (10,52,
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194). The effects o f bicycle exercise on these immune parameters were more pronounced
when individuals suffered from emotional strain (195). Epinephrine injection modified
immune functions in a similar manner except that increased B cells were measured
following exogenous administration o f this amine to human subjects (196). Response o f
individuals to stress varies considerably for reasons which have not yet been clearly
elucidated.
Studies on exercise-induced changes in immune function have largely been based
on two models. Acute stress test models typically include individuals subjected to a single
bout o f exercise and neuroendocrine-immune interactions are studied before and after the
stress test (178). Chronic exercise stress models have been used to study the incidence o f
disease in elite athletes and neuroendocrinological and immunological endpoints have
generally been analyzed in relationship to disease episodes (177). Very little is known
about the effects o f chronic moderate exercise programs on immune function. Significant
progress in this research area will require a model that takes into account physical and
psychological factors that influence exercise activity and neuroendocrine-immune
interactions.
Equine influenza A virus is a major cause o f respiratory disease in horses (1).
Most efforts to control epidemics o f equine influenza relay on vaccination programs.
However, antibody titers induced by vaccination rapidly decline and the protection
conferred by vaccination is short lived (1). Thus, it is o f considerable interest that
treatment regimes which improve the response to vaccination be identified. Based on
results from other species, it is conceivable that short-term pharmacological manipulations
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o f catecholaminergic systems might be used in conjunction with vaccination regimes in
order to enhance primary and/or secondary antibody responses for purposes o f improving
the protection against influenza infections. The present study was aimed at gaining a
better understanding o f the relationship between in vivo release o f catecholamines and in

vitro immunological responses to mitogen and influenza virus. Lymphoproliferation was
tested for peripheral blood mononuclear cells (PBMCs) collected from horses subjected to
sham, psychological, and exercise stress tests.
B. Materials and Methods
1. Horses
Seven horses were used for these experiments. Description and maintenance o f
horses were described in Chapter three.
2. Stress Test Regimes
Five different stress tests were performed. Details o f each stress test and the
number o f horses included in each test were described in Chapter three.
3. Sample Collection, Catecholamine Quantification, and Lymphoproliferation
Assays
Samples were collected 60 minutes prior to beginning o f each stress test, at the
beginning o f the stress test (0 minutes), and at 5, 10, 15, 30, 45, 60, and 120 minutes after
the start o f each stress test. A recently validated HPLC method was used to measure
circulating concentrations o f epinephrine (E) and norepinephrine (NE) at the
aforementioned time points (197).
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Immunological assays measured equine influenza virus (EIV)- and pokeweed
mitogen (PWM)-induced lymphoproliferation. These assays were performed as described
in Chapter three using PBMCs collected at four time points. Samples were collected 60
minutes before the start o f each stress test (T^,), and at 13 (T+13), 33 (T+33), and 73 (T .^)
minutes after the start o f each stress test. Influenza-specific lymphoproliferation was only
tested with dose 2 EIV (16 HA U) and EIV was incubated with PBMCs for 5 or 7 days.
Mitogen-induced lymphoproliferation was tested for PBMCs cultured for 5 days in the
presence o f 2 pg o f pokeweed mitogen (PWM).
4. Statistical Analysis
Samples from each horse were assayed in triplicate. Data were analyzed using
repeated measure analysis o f variance. Lymphoproliferation results in cpm were
converted to a percentage o f cpm measured for pretreatment (T^j) results. Pairwise
comparisons (Tukey’s t test) were done to determine whether ElV-specific and/or
mitogen-induced lymphoproliferation measured during the stress tests were significantly
different from lymphoproliferation measured for pretreatment samples. Basal and stressinduced amine concentrations were also compared using Tukey’s t test. Correlation
between the circulating catecholamine concentrations and lymphoproliferation was
analyzed using Pearson and Spearman methods.
C. Results
1. Circulating Concentrations o f Catecholamines in Different Stress Tests
Table 4 lists physiological concentrations (mean ± SE) o f amines in samples
collected from resting and stressed horses. The mean basal concentration o f NE in
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Stress Tests

Norepinephrine (pg//d)

Epinephrine (pg//d)

Further reproduction
prohibited without p e r m is s io n .

Basal

Stress-induced

Basal

Stress-induced

Sham/stall

67.92 ± 17.06

74.16 ± 6 .7 6

79.80 ± 17.19

49.38 ± 6.53

Sham/psych

28.69 ± 9.10

56.14 ± 7.74

41.64 ± 6 .1 0

43.98 ± 5.36

Minimal

79.22 ± 11.83

71.02 ± 4 .0 2

38.70 ± 6 .1 7

44.18 ± 2.37

Slow gallop

147.35 ± 58.29

121.92 ± 17.96

149.13 ±30.97

296.01 ±62.79*

Fast gallop

56.80 ± 21 .3 4

46.64 ± 5 .9 2

30.34 ± 3 .8 8

409.65 ±63.07*

Mean amine concentrations (± SE) are in pg/^1 for samples collected from resting horses (basal) and for samples collected at 5,
10, 15, 30, 45, and 60 minutes after the start o f the stress test. Values for samples collected after the start o f the stress test (5 to
60 minutes) were pooled to calculate mean stress-induced concentrations o f amines since there were no significant differences
between these time points. Significant differences between basal and stress-induced concentrations o f E are marked with an
asterisk (*). Stress tests included: Sham/Stall (Sham/stalled; n~-6), Sham/psych (Sham/psychological; n=6), Minimal (Minimal
exercise stress; n=6), Slow Gallop (Slow gallop/moderate exercise stress; n=6), Fast Gallop (Fast gallop/intense exercise stress;
n-6).
-j
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samples collected before the stress tests was 76.00 ± 18.00 pg/^1. There were no
significant differences between basal concentrations o f NE measured before the different
stress tests and stress-induced concentrations o f NE measured during the sham/stalled,
sham/psychological, minimal exercise, slow gallop/moderate exercise, and fast
gallop/intense exercise stress tests.
The mean basal concentration o f E was 67.90 ± 20.10 pg/^1. Epinephrine
concentrations in equine samples were highly variable at various time points and during
different stress tests. However, there was about a two to three fold stress-induced
increase (P<0.05) in the concentrations o f E measured for horses subjected to the slow
gallop/moderate exercise and fast gallop/intense exercise stress tests. The sham/stalled,
sham/psychological, and minimal exercise stress tests did not alter (P>0.05) serum E
concentrations.
2.

ElV-specific and Mitogen-induced Lymphoproliferation

Table 5 summarizes lymphoproliferation data for horses subjected to the different
stress tests. Influenza-specific lymphoproliferation was significantly increased by the
sham/stalled stress test. The sham/psychological, minimal exercise, and slow
gallop/moderate exercise stress tests did not significantly effect ElV-specific
lymphoproliferation. Data for the fast gallop/intense exercise stress test could not be
analyzed since the T^, sample was lost during processing.
There was a main effect (P<0.05) o f time and stress test on mitogen-induced
proliferation. The minimal exercise stress test decreased (P<0.05) PWM-induced
blastogenesis. The sham/stalled, sham/psychological, and slow gallop/moderate exercise
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Table 5: Lymphoproliferative Response o f PBMCs Collected During Different Stress
Tests

Stress Tests

Influenza-Specific Lymphoproliferation
(% T-60 SI)

Mitogen-induced
Lymphoproliferation
(% T.60 SI)

5 Day Cultures

7 Day Cultures

Sham/stall

91.75 ± 3 9 .6 6

388.10 ± 143.65'

135.94 ±41.94

Sham/psych

118.73 ± 33.98

110.38 ±38.84

176.81 ±53.94

Minimal

280.72 ± 167.47

157.41 ±62.04

18.89 ± 6 .5 0 '

Slow gallop

62.15 ± 9.61

173.15 ± 132.33

100.90 ±43.40

Fast gallop

No data

No data

No data

There was no effect (P>0.05) o f time on proliferative response o f PBMCs collected after
the start o f the stress tests. The mean cpm o f the proliferative response for cells collected
at T+13 and T+33 was divided by the cpm measured for the lymphoproliferative response of
PBMCs collected at T ^ . Values in each column are listed as the mean percentage o f the
pretreatment (T ^ ) ± SE. Values that reflect a significant effect o f stress on
lymphoproliferation are marked with an asterisk (*). The T ^ sample for the fast
gallop/intense exercise stress test was lost. See legend below Table 4 for a list o f
abbreviations.
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stress tests did not effect (P>0.05) PWM-induced lymphoproliferation. Data for the fast
gallop/intense exercise stress test could not be evaluated due to loss o f the

sample.

3.
Relationship o f Catecholamine Concentrations to Influenza-specific and
Mitogen-induced Lymphoproliferation for Samples Collected During the Five Different
Stress Tests
Epinephrine was significantly increased during the slow gallop/moderate exercise
and the fast gallop/intense exercise stress tests. Lymphoproliferation was not effected by
the slow gallop/moderate exercise stress test and data was not available to determine
whether the fast gallop/intense exercise stress test effected lymphoproliferative responses.
For the data that were available, there was no significant correlation between serum
catecholamine concentrations and lymphoproliferation.
D. Discussion
Numerous peptides, steroids and amines are released in response to a particular
stressor (4, 18). However, Selye’s (97) original definition o f stress was based on the
premise that cortisol and catecholamines are always released in response to stress.
Current literature clearly indicates that the amount o f these compounds that is released
varies depending upon the nature and duration o f a stress as well as a number o f
contributing factors. Nevertheless, it is fundamental to our understanding of
neuroendocrine-immune interactions that we elucidate the role that catecholamines play in
regulating immune functions.
Interest in catecholaminergic regulation o f immune function increased when it was
reported that stress-induced changes in immunity occur in adrenalectomized and
hypophysectomized rats (192, 193). Recent reports also indicate that lymphoid tissues are
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innervated by sympathetic nerve fibers and that immunocompetent cells possess high
affinity adrenergic receptors (37). Catecholamine release caused by physical or
psychological stress depends on activation o f the CNS and the related response o f the
ANS (79). Acute systemic release o f catecholamines during exercise stress has been
related to reduced lymphoproliferation in murine experimental models (78). Further,
denervation and/or pharmacological treatments that prevent neurotransmitter release in or
from the adrenal medulla, thymus, or lymph nodes may alter specific immunological
functions such as in vivo proliferation o f immune cells in lymph nodes, spleen, and bone
marrow (21, 80). Chemical sympathectomy also reportedly diminished the primary
antibody response in mice by as much as 80% and 97% in spleen and lymph nodes,
respectively. Denervation and/or pharmacological block o f sympathetic transmitter
release also reduced the secondary antibody response and resulted in a 50% reduction in T
cell-mediated responses including delayed hypersensitivity to epicutaneous immunization
and cytotoxic T-lymphocyte response to alloantigens. The same experimental reports
described enhanced lipopolysaccharide-stimulated proliferation and enhanced
immunoglobulin production by lymph node cells following denervation or pharmacological
block o f sympathetic activity (37, 80).
Catecholamine concentrations measured before and during the stress tests widely
fluctuated within and among horses. Norepinephrine concentrations were not significantly
effected by any stressor. Epinephrine concentrations were elevated two fold when horses
were subjected to more strenuous physical exertion associated with the slow and fast
gallop exercise tests. The sham/stalled, sham/psychological, and minimal exercise stress
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tests did not change E concentrations when stress-induced amine concentrations were
compared to basal concentrations. These results suggest that only the slow
gallop/moderate exercise and fast gallop/intense exercise groups were stressed based on
the premise that stressors always cause the release o f glucocorticoids (data not shown)
and catecholamines from the adrenal gland. These results would also be desirable since it
was originally proposed that the sham/stalled, sham/psychological, and minimal exercise
stress tests would serve as controls that would help us determine whether sampling
procedures and/or behavioral/psychological factors might be confounding results from the
exercise stress tests.
Data from this experiment indicated that ElV-specific lymphoproliferation was
increased over baseline in horses subjected to the sham/stalled stress test. Mitogeninduced blastogenesis measured in this experiment was inhibited by minimal exercise stress
and not altered by the other stressors. Keadle (123) previously reported that exercise
regimes identical to that used for our slow gallop/moderate exercise and our fast
gallop/intense exercise stress tests inhibited ElV-specific and PWM-induced blastogenesis
o f equine PBMCs. It is not clear why results from the present project differ from the
previous report. However, a number o f factors may account for this discrepancy. Firstly,
effects o f the stress tests on EIV-induced blastogenesis were only observed when PBMCs
were cultured 7 days in these experiments. There was no effect o f stress on EIV-induced
proliferation when cells were cultured for 5 days. The effects on PWM-induced
proliferation in this experiment were found for PBMCs that were cultured 5 days. Keadle
(123) utilized bulk cultures o f PBMCs and assayed lymphoproliferation on days I, 3, 5, 7,
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and 9. It is unlikely that the effects o f exercise stress on EIV- or mitogen-induced
blastogenesis were equivalent on each o f these days and for the results that were shown
there was no indication o f the number o f days that the PBMCs had been cultured. Thus, it
is possible that the apparent discrepancy in our results is because we are reporting results
for cells cultured for a different number o f days.
Secondly, 1.6 or 16 HA U o f EIV stock was used to stimulate equine PBMCs in
these experiments. Keadle (123) reportedly tested the response of equine PBMCs to 0.4S
or 4.8 HA U o f EIV. Some evidence suggests that immunological effects o f stress-related
hormones may only be observed when the appropriate suboptimal dose o f mitogen is used
(73).
Lastly, when the stimulation indices were calculated for ElV-specific and mitogeninduced lymphoproliferation measured in this experiment they were rather low. However,
they were still in the acceptable range. Stimulation indices for Keadle’s (123) data are not
known. Further work is needed to clarify effects o f various stressors on
lymphoproliferation o f equine PBMCs.
A primary goal o f this experiment was to determine if there was a relationship
between acute stress-induced changes in catecholamine secretion and in vitro
lymphoproliferation. Results from this experiment indicate there is not a relationship
between these two endpoints. However, results from in vitro experiments have
demonstrated that lymphoproliferation may be altered by catecholamines (175, 176, 190,
196). Denervation studies also clearly demonstrate an important effect o f catecholamines
on various immune functions (21). Thus, it may be that circulating catecholamines are o f
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little importance to acute changes in immune function and that long-term neurocrine
actions are most important for adrenergic effects on immune cells.
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CHAPTER VI: CATECHOLAMINES MAY ACT THROUGH BETA
ADRENERGIC RECEPTORS TO EFFECT LYMPHOPROLIFERATION OF
EQUINE PERIPHERAL BLOOD MONONUCLEAR CELLS

A. Introduction
Multiple pathways o f communication between the neuroendocrine and immune
systems have been described (6). Noradrenergic innervation o f primary and secondary
lymphoid organs in humans, rats, and mice (21, 198) suggest that neural effects on the
immune system are likely to be important in most species. Further, anatomical
compartmentalization o f noradrenergic innervation in lymphoid organs has been suggested
to reflect specific effects o f catecholamines (norepinephrine, epinephrine) on distinct
immune cell types (37).

Whether or not basal or stress-induced concentrations o f

catecholamines consistently effect function o f the immune system in the equine species has
not been determined.
Adrenergic receptors include alpha and beta classes. Alpha-adrenergic receptors
are further classified into sub-types include alpha-1, alpha-2a, or alpha-2b. Betaadrenergic receptors are classified into two sub-types which have been designated as beta1 or beta-2. Each adrenergic receptor sub-type acts through a specific second messenger.
Alpha-1 receptors elevate phospholipase C (PLC) and phospholipase A2 (PLA2) second
messenger systems (199). Alpha-2a and 2b receptors reportedly decrease cAMP and C a"
levels (199). Beta-1 receptors were reported to increase cAMP and C a " (25) whereas
beta-2 receptor activation results in increased cAMP (25). Adrenergic receptors have
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been characterized on T and B lymphocytes (84, 200), macrophages (94), neutrophils
(119), NK cell populations (201), leukocyte sub-sets (85), and CD4+ and CD8^ cells (93).
The effects o f catecholamines or aminergic agonists on equine influenza virus
(EIV) specific- and pokeweed mitogen (PWM)-induced (non-specific) lymphoproliferation
o f PBMCs were analyzed in this experiment. Results from the present study were
expected to provide additional evidence for a direct effect o f catecholamines on equine
immune cells. It was also hoped that results from this study would help to clarify types o f
adrenoceptors which may be involved in catecholamine effects on the immune system in
the equine species. Finally, these experiments tested for effects o f catecholamines on EIVspecific lymphoproliferation.
B. Materials and Methods
1. Horses
Four horses were used for this experiment. Identity, care, and maintenance o f
these horses were described in Chapter three.
2. Preparation o f Compounds
Test compounds (Sigma Chemical Co., St. Louis, MO) included norepinephrine
(NE, -arterenol), (+) epinephrine (E), methoxamine-HCl (M), and isoproterenol (I).
Concentrations used in the experiment were 1C6, 1O'9, and 10'12M forN E ; 10"6, 10'*, 10'\
IQ-iu, jg- 12, ancj io ‘14m for E; and 1C4, 1C6, and 10'8M for M and I. All compounds were
weighed and stored in a dark air tight desiccated environment at -85° C until PBMCs were
available for the in vitro experiments.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

81
3. Sample Collection and Lymphoproliferation Assays
Blood samples were collected from resting horses at 7:00 AM while the animals
were on pasture. Sampling procedures were described in Chapter three.
Lymphoproliferation assays evaluated alpha- and beta-adrenergic effects on EIV-induced
and PWM-induced lymphoproliferation as described in Chapter three. Test compounds
were dissolved in media at twice the final concentration. This was done just before the
addition o f compounds to the cultures.
4. Statistical Analysis
All samples were assayed in quadruplicate and each assay was done once for each
o f the four horses used for this experiment. Data were analyzed to determine the effects
o f amines and aminergic agonists on in vitro lymphoproliferation using one way analysis
o f variance. Dunnett’s t-test was used for pairwise comparisons to determine if treatment
with different concentrations o f each compound resulted in a significant difference as
compared to results measured for the control.
C. Results
1. Effects o f Norepinephrine on Lymphoproliferation o f PBMCs Cultured for 5
Days
EIV- and mitogen-induced lymphoproliferation were measured for cultures treated
with three different concentrations o f norepinephrine. Lymphoproliferation was calculated
as the stimulation index. Lymphoproliferation for control cultures stimulated with 1.6 HA
U o f EIV (dose 1), 16 HA U o f EIV (dose 2), and PWM (2 pg/ml media) were 3.05 ±
0.89, 3.98 ± 0.04, and 5.88 ± 0.62, respectively (Figure 10). Proliferative response o f
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AMINE CONCENTRATION

Figure 10: Effects of norepinephrine (NE) on lym phoproliferation of PBMCs
cultured for 5 days. Influenza-specific and mitogen-induced lymphoproliferative
responses were measured for cells collected from resting horses (n=4) and treated with
mitogen or mitogen and three different concentrations o f norepinephrine. Cultures were
incubated with two doses of EIV [dose 1 (1.6 HA U); dose 2 (16 HA U)] or one dose o f
PWM (2 pg/ml). Lymphoproliferation was calculated as the stimulation index for mitogen
plus media controls ( c ) or for cultures which were incubated with mitogen and I O'12, 10'9,
or I O'6 M NE. Background cpm were 18038, 12262, 17996, and 17512 for PBMCs
cultured only with media, or with I O'6, 10'9, and 10'12 M NE in media, respectively. Data
were analyzed by one way ANOVA and means for each treatment group were compared
to the control using Dunnett’s t-test. Means (± SE) that were significantly different
(P<0.05) from the controls were marked with an asterisk (*).
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control cultures treated with mitogens was low but acceptable since stimulation indices
were greater than 2.
Mitogen-induced lymphoproliferation was stimulated (P<0.05) when PBMCs were
cultured with 10'12 M NE (13.93 ± 1.85). At 10'9 and I O'* M doses o f NE there was no
significant effect on mitogen-induced lymphoproliferation. Influenza-specific
lymphoblastogenesis was also not effected (P>0.05) by NE treatments.
2. Effects o f Epinephrine on Lymphoproliferation o f PBMCs Cultured for 5
Days
Influenza-specific and mitogen-induced lymphoproliferation were measured for
cultures treated with five different concentrations o f epinephrine (Figure 11). Stimulation
indices for control cultures were 2.79 ± 0.79, 3.13 ± 0.62, and 4.48 ± 0.69 for EIV dose
1, EIV dose 2, and PWM-treated cultures, respectively. There were no significant effects
o f E treatment on ElV-specific and mitogen-induced proliferative responses.
3. Effects o f Alpha-Adrenergic Agonist on Lymphoproliferation o f PBMCs
Cultured for 5 days
The alpha-adrenergic agonist used in this experiment was methoxamine which is
specific for the alpha-1-adrenergic receptor class (84). Influenza-specific and mitogeninduced proliferation were not effected (P>0.05) by any dose o f M (Figure 12).
4. Effects o f Beta-Adrenergic Agonist on Lymphoproliferation o f PBMCs
Cultured for 5 Days
Isoproterenol was used as the beta-adrenergic agonist in these experiments. This
compound may act through both beta-1 and beta-2 adrenoceptors (84). Stimulation
indices were 2.79 ± 0.79 and 3.13 ± 0.62 for control cultures treated with ElV-dose 1 and
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Figure 11: Effects of epinephrine (E) on lym phoproliferation of PBMCs cultured
for 5 days. Influenza-specific and mitogen-induced lymphoproliferation were measured
for cells collected from resting horses (n=4) and treated with five different concentrations
o f E. Cultures were incubated with two doses o f EIV [dose I (1.6 HA U); dose 2 (16
HA U)], or one dose o f PWM (2 pg/ml). Lymphoproliferation was calculated as the
stimulation index for media controls (c ) or for cultures which were incubated with
mitogen and 10"u , 10'a , 10'10, 10‘9, or 10"6 M E. Background cpm for PBMCs cultured
only with E or media were 18038 (media), 13995 (lO^M E), 12631 (10-9M E), 11680
(10'1°M E), 12271 (10*I2M E), and 14843 (10'14M E). Data were analyzed by one way
ANOVA and means for each treatment group were compared to the control using
Dunnett’s t-test. There were no significant effects o f E on EIV- or mitogen-induced
proliferative responses.
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Figure 12: Effects of alpha-adrenergic agonist on Iym phoproliferation of PBMCs
cultured for 5 days. Influenza-specific and mitogen-induced Iymphoproliferation were
measured for cells collected from resting horses (n=4) and treated with mitogen or
mitogen plus three different concentrations o f methoxamine. Cultures were incubated
with two doses o f EIV [dose I (1.6 HA U); dose 2 (1 6 HA U)] or one dose o f PWM (2
pg/ml). Lymphoproliferation was calculated as the stimulation index (mean ± SE) for
media controls with mitogen (c ) and mitogen-treated PBMCs that were incubated with
10‘s, I O'6, or 10-4 M methoxamine. Background cpm for PBMCs cultured in media or
media with methoxamine were 18038, 20950, 15736, and 19243 for media, 10"4, I O'6, and
10'8M M, respectively. Data were analyzed by one way ANOVA. Methoxamine
treatments did not effect (P>0.05) specific and non-specific lymphoproliferation measured
in these assays.
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ElV-dose 2 (Figure 13). Stimulation indices for ElV-dose 1-treated cultures were not
significantly different from the control when PBMCs were incubated with isoproterenoi.
Stimulation indices for ElV-dose 2 cultures treated with isoproterenol were also not
significantly different from the control stimulation index.
The stimulation index for control cultures treated with PWM was 4.48 ± 0.69.
Stimulation indices for PWM-treated cultures incubated with I O'" and I O'6 M
concentrations o f isoproterenol were not significantly different from the stimulation index
for control cultures. Lymphoproliferation for PWM-treated control cultures was lower
(P<0.05) than that measured for PBMCs incubated with PWM and 10~*M isoproterenol
(11.23 ±2.13).
D. Discussion
Certain physiological and pathological conditions can elicit neurotransmitter
release in the proximity o f immunoproficient cells (202). Consequently, neurotransmitters
may effect cellular, metabolic, and functional processes by binding to various classes of
membrane receptors. Catecholamines have been reported to act on the immune system in
nanomolar concentrations through neurotransmitter and paracrine modes. Acute
sympathetic activation resulting from exercise bouts or psychological stress causes a
selective increase in circulating NK (CD56') cells that are rich in P-adrenergic receptors
(85). Results from the same laboratory indicated that the effects o f stressors on bfK cells
could be mimicked by intravenous infusion o f epinephrine (85). However, in vitro
experiments have suggested that P-adrenergic receptor activation results in
immunosuppression (90, 203) and that epinephrine acts through this receptor class to
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Figure 13: Effects of beta-adrenergic agonist on Iymphoproliferation of PBMCs
cultured for 5 days. Influenza-specific and mitogen-induced lymphoproliferative
responses were measured for ceils collected from resting horses (n=4) and treated with
mitogen (c ) or mitogen plus three different concentrations of isoproterenol. Cultures
were incubated with two doses of EIV [dose 1 (1.6 HA U); dose 2 (16 HA U)] or one
dose of PWM (2 ug/ml). Lymphoproliferation was calculated as the stimulation index
(mean = SE) for media controls incubated with mitogen and mitogen-treated cultures that
were incubated with 10'®, I O'0, or IQ"1M isoproterenol. Background cpm for PBMCs
cultured with I were 18038, 11521, 15598, and 18398 for cells cultured only in media, or
with 10"\ 10", and 10'8 M I in media, respectively. Data were analyzed by one way
ANOVA and means for each treatment group were compared to the control using
Dunnett’s t-test. Significant differences (P<0.05) as compared to the control were marked
with an asterisk (*).
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suppress NK cell activity in humans (201). Results from this experiment demonstrated
that norepinephrine and isoproterenol elevated PWM-induced lymphoblastogenesis.
However isoproterenol did not effect ElV-induced proliferation o f PBMCs.
The role o f alpha-adrenoceptor stimulation in lymphocyte activation is not clear.
Recent findings suggest that alpha-1, alpha-2a, and alpha-2b adrenoceptors play a
modulatory role in the lymphocyte response (90, 203). Catecholamines enhanced
proliferation o fC D 3 \ C D 4 \ and CD8+ lymphocytes by a-adrenergic stimulation whereas
P-adrenergic stimulation inhibits proliferation o f human lymphocytes (84). These effects
were more pronounced for CD8" lymphocytes than for C D 4' cells (93). Results from this
experiment indicate that low concentrations o f NE stimulate PWM-induced growth.
However, the alpha-1 agonist did not effect lymphoproliferation. Keadle (123) reported
that PWM-induced lymphoblastogenesis was inhibited by NE or E when PBMCs were
collected from unconditioned horses. Methoxamine and isoproterenol depressed PWMinduced lymphoproliferation o f PBMCs from unconditioned horses (123). Mitogeninduced lymphoproliferation o f PBMCs from conditioned horses was stimulated by low
concentrations o f isoproterenol (123). There is evidence that lymphocyte responses may
be positive or negative depending on the prevalence o f alpha or beta receptors (93).
Whether agonists that act on a receptor subtype that we did not test for could help to
account for stimulatory or inhibitory effects o f amines on non-specific proliferation
requires further study.
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CHAPTER VH: RELATIONSHIP BETW EEN EXERCISE STRESS-INDUCED
CHANGES IN LYMPHOPROLIFERATION AND CIRCULATING
CORTISOL CONCENTRATIONS IN PONIES

A. Introduction
Stressful events may result in development and progression o f a variety o f medical
disorders. Physical exertion or intense exercise stress may have detrimental effects on
nearly all organ systems o f the body. Response to a single bout o f exercise is generally
short lived whereas repetitive training programs that involve intense exercise may produce
various long-term changes in immune function and susceptibility to disease (108).
In human and equine research models, the amount o f cortisol liberated depends not
only on intensity and duration o f exercise but also on the athlete's training state (123,
182). Results from chronic stress models have shown a slight decrease in cortisol
secretion rather than an increase (22). These results confirm earlier findings showing that
chronic stress, in contrast with acute stress, may not augment cortisol secretion (204,
205). It has also been reported that chronic social stress leads to a prolonged increases in
cortisol secretion without impaired immune function (22). These observations do not
eliminate an immunomodulatory role for cortisol in chronic exercise stress (52).
This set o f experiments was designed to monitor the release o f stress hormones
over time in relation to ElV-specific and mitogen-induced lymphoproliferation.
B. Materials and Methods
1. Ponies
Eight unconditioned ovariectomized ponies, two to four years o f age, were used
for this experiment. They were not halter trained or regularly handled prior to being
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assigned to the project. Handling they received prior to this project was limited to
required vaccinations, regular deworming, and farrier work. All ponies were maintained
on pasture before they were assigned to this study. At the start o f the project, ponies were
housed two per box stall and they were fed 8 quarts o f Omalene pellets at 8:00 AM and
4:00 PM. Water was supplied ad-libitum. They were ovariectomized approximately 4
weeks before the beginning o f the experiments. All ponies were vaccinated
intramuscularly with a commercially available influenza virus vaccine in May o f 1994.
Each pony received 2 doses o f inactivated influenza vaccine (influenza A/equine/H3N8,
influenza A/equine/H7N7), 14 days apart, per label instructions (Fort Dodge, IA).
Ponies were randomly divided into two groups. Four o f the ponies were
maintained as a control group and the remaining ponies were assigned to the stressed
group. Experiments included three separate acclimation periods and various stress tests.
Stress tests, vaccination, and acclimation periods were performed on the dates listed in
Table 6.
2. Stress Test Regimes
Ponies were acclimated to the treadmill, rested, and subjected to the stress tests on
the dates listed in Table 6. Details o f these experimental manipulations are described
below.
a.

Acclimation periods. There were four separate acclimation periods,

which were designated acclimation-I, -Ila, -lib, and -EH. The control group was subjected
to acclimation-I, -Ila, and -lib whereas the stressed group was subjected to acclimation-I,
-Ila, and -III. During acclimation-I, ponies were walked for 5 to 10 minutes on the
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Table 6: Dates for Vaccination, Stress Tests, and Acclimation Periods

Control ponies

Stressed ponies

Vaccination (5/94)

X

X

Baseline endpoint measurement (5/30/94)

X

X

Acclimation-I (6/1/94 - 6/19/94)

X

X

Minimal exercise stress test (6/20,21/94)

X

X

Acclimation-IIa (6/22,23/94)

X

X

Resting period (6/24/94 - 6/26/94)
Acclimation-IIb (6/27/94 - 11/11/94)

X

X

Slow gallop/moderate exercise stress (6/27,28/94)

X

AccIimation-III (6/29/94 - 7/6/94; 7/9/94 - 7/14/94)

X

Fast gallop/intense exercise stress (7/7,8/94)

X

Procedures are listed in the order that they were performed. Boxes with an x indicate that
a particular group was subjected to a procedure. A blank box indicates that the group was
not included in that part o f the experiment. Ovariectomy was performed by a licensed
veterinarian approximately 4 weeks before the stress tests were started.
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treadmill at 1.4 meters/second (m/s) for 19 days. This was followed by acclimation-IIa
which included a 4 minute walk at 1.2 m/s, a 4 minute trot at 2.0 m/s, and finally a 5
minute walk at 1.2 m/s for 2 days. Ponies were rested for 3 to 4 days prior to the day of
the minimal exercise stress test. After the minimal exercise test, all ponies were
maintained on the acclimation-IIa protocol for 2 days. Control animals were subsequently
maintained for approximately 5 months on the acclimation-IIb protocol which consisted of
treadmill exercise identical to that described for acclimation-IIa.
Ponies in the stressed group were rested for 3 to 4 days prior to the slow
gallop/moderate exercise stress test. After the moderate exercise stress test, ponies in the
stressed group were subjected to the acclimation-HI protocol where they walked for thirty
seconds at 1.2 m/s, trotted for 1 to 1.5 minutes at 2.5 m/s, and galloped for 3 to 4 minutes
at 6.5 to 7.5 m/s. Then they galloped for 4 minutes at 7.0 to 7.5 m/s on a 6% or 7%
incline, trotted for 2 minutes at 2.5 m/s, and finally walked for 4 minutes at 12 m/s.
Ponies were maintained on the acclimation-HI protocol for 10 days.
b.

Stress tests. The tests included a minimal exercise stress, slow

gallop/moderate exercise stress, and a fast gallop/intense exercise stress. The minimal
exercise stress test utilized a protocol where ponies in both groups (n=8) walked on the
treadmill for 25 minutes at 1.2 m/s. The minimal exercise stress test was done to
determine whether endocrine and/or immunological parameters would be modified by lowlevel physical exertion. The test was started at 7:00 AM and it ended at 11:00 AM when
the last sample was collected from the last pony. Two control and 2 stressed group
animals were tested per day so that it took 2 days to complete this test.
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Ponies in the stressed group completed the slow gallop/moderate exercise stress
test. This test included a 1.0 minute walk at 1.2 m/s, a 2.0 minute trot at 2.5 m/'s, an 8.0
minute gallop at 6.5 to 7.5 m/s, a 5.0 minute gallop at 8 m/s, a 2.0 minute trot at 2.5 m/s,
and a 1.0 minute walk at 1.2 m/s. This test was done to determine whether moderate
physical exertion had an effect on endocrine and/or immunological endpoints included in
this study. The slow gallop/moderate exercise stress test was started at 7:00 AM and
ended when the last sample was collected. Two ponies were tested per day so it took 2
days to complete this stress test.
Finally, a fast gallop/intense exercise stress was performed where the stressed
group ponies were walked for I minute at 1.2 m/s, followed by a 2 minute trot at 2.5 m/s,
a 1 minute gallop at 7.0 m/s on a 6% incline, a 7 minute gallop at 7.0 m/s on a 7% incline,
a trot for 2 minutes at 2.5 m/s, and a 12 minute walk at 1.2 m/s. The fast gallop/intense
exercise stress test was performed to determine whether intense physical exercise effected
our experimental endpoints. This test was started at 7:00 AM and ended when the final
sample was collected from the last pony around 10:00 AM on each day o f the test. Two
ponies were tested per day and the test was done on two consecutive days.
Pre-test handling was the same for all ponies. Ovariectomized ponies were
catheterized through the jugular vein between 3:30 and 4:30 PM on the day before the
start o f each stress test. Catheters were flushed using physiological saline (0.9% NaCl) at
10:30 PM on the same day. On the day o f the stress test, food and water were withheld
until the last sample was collected.
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Each pony spent about 25 minutes on the treadmill during the exercise stress tests.
All ponies were cooled down about 15 minutes after they got o ff the treadmill.
3. Sample Collection and Analysis
Baseline endocrine and lymphoproliferation data were collected at the beginning of
the project. Blood samples were collected from resting ponies to measure baseline
circulating cortisol concentrations. Five samples were collected at 15 minutes intervals.
Radioimmunoassay (RIA) was used to measure cortisol concentrations in plasma samples.
A single blood sample was collected at the same time in order to measure equine influenza
virus (ElV)-specific and mitogen-induced lymphoproliferation.
Blood samples for cortisol RIA were collected one hour prior to the beginning of
each stress test, at the beginning o f the stress tests, and at 5, 10, 15, 20, 25, 30, 45, 60,
and 120 minutes after the start o f each stress test. A recently validated HPLC method
(Chapter three) was used to analyze circulating concentrations o f epinephrine and
norepinephrine in samples collected one hour prior to the beginning o f each stress test, at
the beginning o f the stress tests, and at 5, 10, 15, 30, 45, 60, and 120 minutes after the
start o f each stress test.
Assays for EIV-, phytohaemagglutinin (PHA)-, and pokeweed mitogen (PWM)induced lymphoproliferation were performed as described in Chapter three using PBMCs
collected at four time points. Samples were collected 60 minutes before (T^0) each stress
test and at 13 (TM3), 33 (T„33), and 73 (T ,73) minutes after the start o f each stress test.
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4. Statistical Analysis
All samples were analyzed in triplicate or quadripulicate. Data were analyzed
using repeated measure ANOVA to determine the effect o f stress on circulating cortisol
concentrations, ElV-specific proliferation, and mitogen-specific lymphoproliferation.
Spearman and Pearson methods o f statistical correlation w ere performed to determine the
relationship between circulating cortisol concentrations and lymphoproliferation. Pairwise
comparisons were made using Tukey’s t test in order to identify significant differences in
specific or non-specific lymphoproliferation and circulating cortisol concentrations within
and between the two groups o f animals.
C. Results
1.
Baseline Cortisol Concentrations and ElV-specific and Mitogen-induced
Lymphoproliferation
Cortisol concentrations are listed in ng/ml (mean ± SE) for the samples collected
from resting ponies (Table 7). The mean baseline cortisol concentration was 1355.08
ng/ml. There was no effect (P>0.05) of time on cortisol concentrations.
Table 8 lists results for EIV-induced lymphoproliferation (mean ± SE) assays. The
EIV dose 1 treatment did not result in an acceptable stimulation index.
Lymphoproliferation induced by EIV dose 2 was 5.85 ± 1.84. Non-specific
lymphoproliferation induced by PHA and PWM was 108.93 ± 12.67 and 123.64 ± 12.65,
respectively.
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Table 7: Cortisol Concentrations in Resting Ponies

Time (minutes)

Cortisol (ng/ml)
Mean

±

0

1471.69

±

148.69

15

1476.64

±

152.41

30

1254.97

±

67.27

45

1251.76

±

191.63

60

1320.35

±

199.67

SE

Samples were collected from resting ponies starting at 8:00 AM and cortisol was
measured using radioimmunoassay. There was no effect (P>0.05) o f time on mean
cortisol concentrations.
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Table 8: Lymphoproliferation o f PBMCs Collected from Resting Ponies

Stimulation Indices (mean ± SC)
EIV (dosel)

0.38

±

0 .1 1

EIV (dose2)

5.85

±

1.84

PHA

108.93

±

12.67

PWM

123.64 ±

12.65

Baseline ElV-specific and mitogen-induced lymphoproliferative responses were
determined using four resting ponies. Influenza-specific [EIV dose 1 (1.6 HA U); EIV
dose 2 (1 6 HA U)] Iymphoproliferation was measured after PBMCs were cultured for 5
days and mitogen-induced lymphoproliferation was measured on day 3 using 2 pg/ml of
PHA or PWM.
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2. Effect o f Minimal Exercise Stress on Circulating Cortisol Concentrations and
Lymphoproliferation
Cortisol concentrations in samples collected before, during, and after the minimal
exercise stress test are listed in Table 9. There was no change (P>0.05) in cortisol
concentrations throughout this stress test.
Table 10 lists EIV dose 2-, PHA-, and PWM-induced lymphoproliferation results
for samples collected at the four different time points described in materials and methods.
There were no significant effect o f minimal exercise stress on lymphoproliferation. This
was true for both ElV-specific and mitogen-induced lymphoproliferation.
3. Effect o f slow gallop/moderate exercise stress on circulating cortisol
concentrations and lymphoproliferation
Table 11 shows cortisol concentrations for samples collected at eleven different
time points. Cortisol concentrations measured in samples collected one hour before the
test and at the beginning o f the stress test were 2276.08 ± 217.01 and 1857.56 ± 141.22
ng/ml, respectively. Cortisol concentrations measured in samples collected at 5, 10, 15,
20, 25, 30, 45, and 60 minutes after the start o f the stress test were decreased (P<0.05) as
compared to the concentrations observed one hour before and at the beginning o f the
stress test. Cortisol concentrations in samples collected 120 minutes after the start o f the
stress test were not significantly different from hormone concentration measured before
the test.
Results for ElV-specific and mitogen-induced lymphoproliferation o f PBMCs
collected during the slow gallop/moderate exercise stress test are listed in Table 12. There
was no significant effect o f time on ElV-specific or mitogen-induced lymphoproliferation.
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Table 9: Cortisol Concentrations in Ponies Exposed to Minimal Exercise Stress

Conditions o f the
Test

Time (minutes)

Cortisol Concentrations
(ng/ml)

Stalled

oo
•~
1

1950.54 ± 134.15

T readmill/standing

0

2068.55 ±70.81

Walk

5

1925.96 ±85.15

Walk

10

2022.84 ± 166.74

Walk

15

1963.02 ± 177.47

Walk

20

1995.74 ± 154.69

Walk

25

2119.21 ± 138.87

Treadmill room

30

1881.53 ± 167.75

Treadmill room

45

2099.41 ±206.86

Stalled

60

2220.47 ± 173.41

Stalled

120

2168.49 ±202.76

Cortisol concentrations in ng/ml (mean ± SE) were determined for samples collected one
hour before the beginning o f the stress test (-60), at the beginning o f the stress test (0),
and at 5, 10, 15, 20, 25, 30, 45, 60, and 120 minutes after the start o f the stress test (n=4).
Cortisol was measured using radioimmunoassay. Data were analyzed by ANOVA. There
was no (P>0.05) main effect o f time on plasma cortisol concentrations.
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Table 10: ElV-specific and Mitogen-induced Lymphoproliferation of PBMCs
Collected from Ponies Exposed to Minimal Exercise Stress

T r e a tm e n t

S tim u la tio n In d ic e s (m e a n ± S E )
T^o

T„3

T-33

T.-3

E IV (dosc2)

3.92 ± 1.89

4.61 ± 1.85

3.45 ± 0 .9 9

3.60 ± 1.53

PH A

26.43 ± 8 .1 1

34.60 ± 9.34

3 5 .47 ± 11.96

49.64 ± 2 3 .6 7

PW M

55.73 ± 15.01

68.95 ± 16.32

6 5 .02 ± 13.60

61.53 ± 2 0 .1 7

Influenza-specific lymphoproliferation was measured on day 5 using 16 HA U o f EIV
(dose 2). Mitogen-induced lymphoproliferation, measured on day 3, was tested with 2
pg/ml o f PHA or PWM. Lymphoproliferative responses are listed as stimulation indices
(mean ± SE) for samples collected one hour prior (T^0) to the beginning o f the stress test
and at 13 (T ,13), 33 (T_33), and 73 minutes (T ,73) after the beginning o f the stress test.
Background media cpm for the EIV culture plates were 180.62, 316.08, 116.88, and
159.00 for samples collected at T.#), T^13> T*33, and T .73, respectively. Background cpm
for PHA and PWM cultures were 127.48, 139.75, 89.16, and 86.70 for samples collected
at T^0, T .13, T ,33, and T ,73, respectively. Data were analyzed by repeated measures
ANOVA. Stress did not significantly effect ElV-specific or mitogen-induced
blastogenesis.
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Table 11: Cortisol Concentrations in Ponies Exposed to Slow Gallop/Moderate
Exercise Stress

Conditions o f the
Test

Time (minutes)

Cortisol Concentrations
(ng/ml)

Stalled

-60

2276.08 ±217.01

T readmill/standing

0

1857.56 ± 141.22

Trot

5

1209.91 ± 193.13*,s

Gallop

10

907.44 ± 11 l.84*,s

Gallop/incline

15

886.65 ± 165.41*-s

Trot

20

816.72 ± 88.43*s

Walk

25

707.77 ± 89.80*,s

Treadmill room

30

892.83 ± 59.39* s

Treadmill room

45

1181.16 ± 125.25*s

Stalled

60

1337.30 ± 145.72* s

Stalled

120

2018.78 ± 191.13

Circulating cortisol concentrations are listed in ng/ml (mean ± SE) for samples collected
one hour prior to the beginning o f the stress test, at the beginning o f the stress test, and at
5, 10, 15, 20, 25, 30, 45, 60, and 120 minutes after the start of the stress test (n=4).
Significant differences between stress-induced cortisol concentrations and hormone
concentrations in the -60 sample are marked with an asterisk (*). Significant differences
as compared to the 0 time point are marked with a dollar sign ($).
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Table 12: ElV-speciflc and Mitogen-induced Lymphoproliferation in Ponies
Exposed to Slow Gallop/Moderate Exercise Stress

Stimulation Indices (mean ± SE)

Treatment
T.«)

T+,3

T-33

T.73

EIV(dose2)

5.79 ± 2.50

8.08 ± 3.62

5.21 ±2.65

6.79 ± 1.00

PHA

28.05 ± 11.57

35.44 ± 9.45

22.83 ±7.21

86.28 ±32.57

PWM

49.73 ± 17.40

43.26 ± 18.18

38.97 ± 12.57

49.35 ± 10.75

Influenza-specific lymphoproliferation was measured on day 5 using 16 HA U o f EIV.
Mitogen-induced lymphoproliferation, measured on day 3, was tested with 2 pg/ml o f
PHA or PWM. Lymphoproliferation results are listed as stimulation indices (mean ± SE)
for samples collected one hour prior (T^,) to the beginning o f the stress test and at 13
(T ,13), 33 (T^33), and 73 minutes (T+73) after beginning o f the stress test. Background cpm
for EIV culture plates were 252.09, 178.46, 733.57, and 260.93 for samples collected at
T-6o>T+i3, T .33, and T .73, respectively. Media blanks for PHA or PWM plates were 86.55,
73.15, 72.54, and 56.14 for each o f the consecutive time points. There were no significant
effects o f stress on proliferative responses.
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4. Effect o f Fast Gallop/Intense Exercise Stress on Circulating Cortisol
Concentrations and Lymphoproliferation
Table 13 lists mean cortisol concentrations in ng/ml for plasma samples collected
at 11 different time points starting one hour prior to the beginning o f the stress test.
Cortisol concentrations decreased during the fast gallop/intense exercise stress test as in
the slow gallop/moderate exercise stress test. Hormone concentrations measured in
samples collected 10 minutes after the start o f the fast gallop/intense exercise stress test
were lower (P<0.05) than cortisol in the -60 and 0 minute samples. Cortisol
concentrations in samples collected at the beginning and at 5, 60, and 120 minutes after
the stress test started were significantly greater (P<0.05) than concentrations measured in
samples collected one hour before the stress test started. Hormone concentrations
measured in samples collected at the beginning o f the stress test were higher (P<0.05) than
cortisol in samples collected one hour before, and at 10, 15, 20, 25, 30, and 45 minutes
after the stress test started.
Table 14 summarizes results for ElV-specific and mitogen-induced
Iymphoproliferation. The fast gallop exercise stress test did not effect (P>0.05) EIVspecific or mitogen-induced lymphoproliferation.
5. Quantitation of Catecholamines in Samples Collected During the Three
Different Stress Tests
Samples were collected during the stress tests in order to measure amine
concentrations at rest, during minimal exercise, moderate exercise, and intense exercise
stress. Catecholamines were undetectable in all samples. This was likely due to
equipment problems that occurred while the samples were in storage.
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Table 13: Cortisol Concentrations in Ponies Exposed to Fast Gallop/Intense Exercise
Stress

Conditions of the
Test

Time (minutes)

Cortisol Concentrations
(ng/ml)

Stalled

-60

1337.82 ± 417.96s

T readmill/standing

0

2476.99 ± 565.34*

Trot

5

2491.39 ±633.18*

Gallop

10

739.95 ± 33.5 l*-s

Gallop/incline

15

849.60 ± 158.70s

Trot

20

1196.75 ± 107.94s

Walk

25

1345.64 ± 182.33s

Treadmill room

30

1553.06 ± 109.16s

Treadmill room

45

1799.86 ± 121.82s

Stalled

60

2041.43 ± 192.18’

Stalled

120

2938.91 ±395.67*

This table lists circulating cortisol concentrations in ng/ml for samples collected one hour
prior to the beginning o f the stress test, at the beginning o f the stress test, and at 5, 10, 15,
20, 25, 30, 45, 60, and 120 minutes after the start o f the stress test (n=4). Significant
differences between stress-induced cortisol concentrations and the -60 minute time point
are marked with an asterisk (*). Significant differences as compared to the 0 time point
are marked with a dollar sign ($).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

R eproduced
with permission

Table 14: ElV-specific and Mitogen-induced Lymphoproliferation in Ponies Exposed to the Fast Gallop/Intense
Exercise Stress
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T reatm ent

Stim ulation Indices (m ean ± SE)

Further reproduction

t

60

T ,l3

T .3 3

T

)73

EIV(dose2)

21.00 ± 15.10

5.41 ± 2,15

15.16 ± 7.36

16.04 ± 7 .6 9

PHA

86.24 ± 12.09

73.88 ± 14.99

72.96 ±22.22

105.09 ± 47.99

PWM

133.09 ± 12.57

104.75 ± 12.24

122.11 ±36.98

154.07 ± 44.42

prohibited without p e rm is s io n .

Influenza-specific lymphoproliferation, measured on day 5, was tested using 16 HA U o f EIV. Mitogen-induced
lymphoproliferation, measured on day 3, was tested by incubating PBMCs with 2 pg/ml o f PHA or PWM. Lymphoproliferative
results are listed as stimulation indices (mean ± SE) for samples collected one hour prior (T 60) to the beginning o f the stress test
and at 13 (T ,13), 33 (T ,33), and 73 minutes (T ,73) after beginning the stress test. Background cpm for the EIV cultures were
198.88, 257.30, 167.41, and 113.48 for the four consecutive time points. Media control cpm for PHA or PWM cultures were
91.53, 83.23, 89.68, and 59.78 for samples collected at T 60, T tl3, T ,33, and T t73, respectively.
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6.
Relationship o f Circulating Cortisol Concentrations to Lymphoproliferation of
PBMCs Collected from Ponies
Circulating cortisol concentrations were not correlated (P>0.05) with EIV-, PHA-,
or PWM-induced lymphoproliferation measured in minimal exercise, slow gallop exercise,
and fast gallop exercise stress tests.
D. Discussion
The endocrine reaction to stress is very complex and only partially understood. As
discussed in earlier chapters, the hypothalamus appears to play a central role in
coordinating the endocrine, autonomic, and behavioral responses to stress. The
hypothalamus exerts neural control over the two main axes involved in the stress response
including the pituitary-adrenocortical and sympathetic-adrenomedullary axis.
This chapter dealt with changes in cortisol secretion in relation to exercise-induced
lymphoproliferation in ponies. Evidence suggest that stress hormones act as mediators for
exercise-induced changes in lymphoproliferation. It is also known that hormones, such as
cortisol, influence leukocyte distribution in the circulation and various organs, including
the spleen, and bone marrow (57).
While cortisol is frequently elevated in response to a variety o f stressors (99),
plasma cortisol levels in ponies decreased during both the slow gallop/moderate exercise
and fast gallop/intense exercise stress tests. This is in contrast to results for horses where
cortisol concentrations increase in response to exercise stressors (73). In this regard, it
should be noted that the adrenocortical response to stress is dependent on the individual
perception o f the stress and an individuals prior history (204, 206, 207). Further, there is
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considerable individual variability in the glucocorticoid response to exercise stress.
Individual differences in exercise capacity can result in large differences in stressdependent changes in the hormone milieu (195). Very little, if any, research has been done
on ponies in this regard, which makes it difficult to reconcile the differences between
horses and ponies. However, the reader is reminded that these ponies were never
regularly handled prior to the start o f the project. All o f the available literature for other
species (204, 206, 207) suggests that the lack o f regular handling in the first few months
after foaling resulted in long-term effects on the response o f adult ponies to regular
exposure to the investigators. Results from this study suggest that handling the ponies
during the project and the relatively unfamiliar housing conditions were more stressful
than intense exercise. This possibility is supported by the high concentration o f cortisol
measured in resting ponies and ponies subjected to the minimal exercise test. In the
present experiment high cortisol concentrations were also measured at the beginning and
the end o f the moderate and intense exercise stress tests. In both o f the latter stress tests
cortisol concentrations were significantly reduced when the animals started to gallop and
they remained low until the exercise stress was close to being stopped. Clinically normal
cortisol concentrations in ponies are 50-70 ng/ml (13, 133). Thus, cortisol concentrations
in the ponies included in this project were persistently elevated.
In general, stress appears to down-regulate the immune response in humans.
However, some hormones have been shown to have stimulatory effects on various
functions of the immune system. As previously mentioned, one should keep in mind the
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type o f stress when interpreting results since different stressors elicit different profiles o f
hormonal changes which in turn result in differential effects on the immune system.
Results from this study did not show significant differences in lymphoproliferation
induced by any o f the stress tests. This could be the result o f the elevated cortisol
concentrations and chronic stress due to prior history o f the animals. It is also possible
that high cortisol may have abolished acute effects o f exercise stress on
lymphoproliferation.
It had been reported that there may be a high correlation between serum cortisol
levels and changes in lymphocytes after exercise (175). Other studies have failed to find a
relationship between serum cortisol and lymphocyte responses (208, 209). Studies
showing a relationship between cortisol and lymphocyte function used intense endurance
exercise models like marathon running in humans whereas studies that failed to show a
correlation used shorter exercise bouts and unconditioned or less fit individuals. We did
not observe a statistical correlation for cortisol and lymphoproliferation regardless o f
exercise intensity. Whether this was due to the nature and duration o f stressors that these
ponies were exposed to is not known at the present time.
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CHAPTER VTH: SUMMARY AND PERSPECTIVES OF THOUGHT FOR

FUTURE RESEARCH

Stress may be associated with anaerobic metabolism, the release o f various
hormones, activation o f the ANS, and altered function o f the immune system. Coincident
changes in neural, endocrine, and immune functions are thought to be the result o f bi
directional communication between the nervous and immune systems in humans (210,
211) and various animal models (204, 212).
Effects o f the CRF-ACTH-glucocorticoid/cortisol system on immune function are
most widely accepted and studied. However, it is now clear that effects o f stress on
immune function may also be independent o f glucocorticoids as stress related downregulation o f immune cell function can be demonstrated even in adrenalectomized and
hypophysectomized rats (192). This research project was based on the assumption that
catecholamines and cortisol probably account for most o f the effects o f exercise stress on
equine immune function due to the prevalence o f adrenergic and cortisol receptors on or
in many immune cell types.
This project also investigated the effects o f stress on equine influenza-specific
lymphoproliferation. Equine influenza infections are prevalent and have a major impact on
the economy o f equine industry. Accordingly, the long term aim o f this project was to
determine whether preliminary data would indicate that pharmacological manipulations o f
endogenous glucocorticoids and/or catecholamine might improve effectiveness o f
influenza vaccinations by increasing the magnitude and duration o f antibody titers that
protect against influenza infections.
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Results from the experiments to quantitate cytosolic and nuclear GRs confirmed
that equine PBMCs have receptors that are responsive to diurnal changes in hormone
concentrations. It may be o f interest to determine cell types that have these receptors in
order to begin to understand the significance o f cortisol effects on equine PBMCs.
Cytosolic GRs were low when cortisol concentrations peak in equine plasma. The highest
nuclear and total binding was observed at 2 PM. This suggests that early morning
increases in cortisol, and the related translocation o f GR to the nucleus, may stimulate GR
synthesis. It is also likely to be related to glucocorticoid-dependent protein synthesis by
equine PBMCs. Nuclear GR was not detectable at 2AM. This suggests that GR would
not interfere with stimuli acting through cAMP and/or protein kinase C at that time point.
Humoral compounds that act through these second messengers could be tested for in vitro
effects on PBMCs collected at various time points o f the day. This might help to explain
differences in the effects o f evening and morning stressor on immune functions.

In vitro ElV-specific and mitogen-induced lymphoproliferative responses o f
PBMCs obtained from the samples collected at the beginning and during the various stress
tests were enhanced, suppressed or unchanged. Significant increases in circulating
catecholamine concentrations were measured in samples collected during slow gallop and
fast gallop exercise stress tests. However, circulating concentrations o f amines were not
correlated with stress-induced changes in lymphoproliferation. Thus, the inhibition or
stimulation of lymphocyte responses may depend on the number o f adrenoceptors on
lymphocytes, the duration and type o f stress, and the duration o f time that cells are
exposed to amines and other hormones.
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Research results from other species suggest that catecholamines may modulate
equine lymphocyte function by acting through surface adrenergic receptors. The in vitro
experimental results demonstrated that catecholamine-induced effects may be mediated by
beta-agonists. Based on these results, lectin-induced lymphoproliferation may be sensitive
to beta-adrenergic receptor activation. However, ElV-induced lymphoproliferation was
not effected by in vitro treatments. It may be o f interest to test for in vitro effects o f other
P-agonists and effects o f a-agonists that were not considered in these experiments. In

vitro experiments with different types o f immune cells treated with catecholamine agonists
and antagonists specific for different sub-types o f adrenoceptors may also help to elucidate
mechanisms underlying catecholamine effects. This becomes particularly important when
one considers factors such as the non-random distribution o f adrenergic receptors on
various immune cells.
Other experiments were designed to investigate the effect o f cortisol on equine
immune function. Cortisol concentrations in all ponies were much greater than clinically
normal concentrations. In exercise stressed ponies a significant decrease in the clinically
abnormal cortisol concentrations was observed. Nevertheless, lowered cortisol in the
exercise-stressed animals was still clinically abnormal. This suggests that prior history o f
the animals made the general experimental conditions more stressful than exercise. Other
researchers have shown that early handling o f newborn rats produces individuals that are
better adapted to novel environments (204, 206, 207). Thus, it may be o f interest to
perform epidemiological studies on the prior history o f horses that become infected with
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EIV after being stressed as adults. This could identify rearing strategies which might
impact on economics o f the equine industry.
There were no significant differences observed in the lymphoproliferative
responses in the different stress tests for ponies. Circulating concentrations o f cortisol
were not correlated with either EIV- or mitogen-induced lymphoproliferation. Elevated
basal levels o f cortisol might have made PBMCs refractory to acute fluctuations in cortisol
concentrations.
Based on the available evidence, single bouts o f exercise may result in
immunosuppressive or immunostimulation. Catecholamines and glucocorticoids may
exert positive and negative effects on lymphocyte responsiveness following exercise.
However, there are many potential modulators o f the immune system that are released in
response to various stressors. Results from this project suggest that compounds which
produce the most pronounced effects on equine PBMCs in vitro should be measured in an
experiment similar to the one that was done with the ponies that were used in this project.
Variations in endocrine and immune endpoints observed in these experiments may
be attributed to differences in the stressors, individual differences in perception and
response to stress, conditioning, immune processes, and differences in receptor
distribution. Studies testing individual and combined actions o f various hormones and
neurotransmitters systems are needed to understand the effects o f stress on immunity and
disease processes. It would also be important to conduct studies using pure cultures of
different immune cell sub-types in conjunction with studies on the effect o f various
compounds on mixed cell cultures.
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It would be worthwhile to test combined effects o f catecholamines and
glucocorticoids since they are likely to interact as part o f their normal effects on immune
cell fractions. For example, glucocorticoids and cAMP have been shown to synergistically
activate transcription o f several genes in human and murine thymoma cells (213). On the
other hand, the cAMP-mediated activation o f a-1 acid glycoprotein gene transcription is
inhibited by glucocorticoids. Molecular studies on the mechanisms underlying these multihormonal effects on gene expression suggest an interaction between PKA-responsive
transcription factors, most notably the CREB protein and GR (76, 77). The interaction o f
humoral factors might also be due to direct modulation o f GR function by PKA since
hormone-dependent trans-activation o f GR in cells may be due, at least in part, to an
increase in DNA binding activity o f GR (214). Results from other experiments indicate
that increased steady state levels o f GR mRNA may be induced by cAMP analogues due
to increased GR mRNA stability (77). In addition, in the presence o f glucocorticoids
cAMP causes cytolysis o f murine lymphoma cells by increasing the level o f steroid binding
(72). This dose-dependent glucocorticoid response was dependent upon the phenotype of
the cAMP-dependent protein kinase (77).
In conclusion, many o f the signals to the immune system from the nervous system
are mediated, to some extent, by intracellular cyclic nucleotides and the responses vary
according to the presence and abundance o f specific receptors. Molecular interactions o f
multiple signaling systems have been reported for steroid hormone and membrane signal
transduction pathways which utilize protein kinases and other second messengers. The
fact that this has been reported for diverse species and the direct in vitro effects o f
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catecholamines and glucocorticoids on equine immune cells suggests that similar
interactions are likely to be important to veterinary medicine.
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